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ABSTRACT 
DAVID P. JOHNSON: Loving-kindness meditation to enhance the psychological recovery 
of individuals with persistent negative symptoms of schizophrenia: A pilot study 
 (Under the direction of David Penn) 
 
  
 Background: A significant subgroup of individuals diagnosed with schizophrenia 
experience persistent negative symptoms, which are particularly important given the 
association with poor long-term functioning and prognosis. Currently, there are few well-
established treatments for negative symptoms. Loving-kindness meditation (LKM) is an 
intervention focused on directing warm, compassionate feelings to the self and others. When 
tested with non-psychiatric samples, LKM was found to improve psychological well-being 
and deficits associated with negative symptoms. Methods: LKM was tested in an 
uncontrolled study design for its feasibility and initial efficacy in a pilot sample of 18 
participants with schizophrenia-spectrum disorders who have persistent negative symptoms. 
Results: Findings suggest that the intervention is feasible and acceptable based on attendance 
rates and feedback from participants. Preliminary data also indicate that LKM was associated 
with increased positive emotions, decreased negative symptoms, and increased psychological 
recovery at post-treatment and 3 month follow-up assessments. Conclusions: Initial data 
about the efficacy of LKM are encouraging although an uncontrolled study design precludes 
strong conclusions until further testing is conducted. If future results are consistent with the 
current pilot study, LKM could be a promising intervention to enhance the recovery of 
individuals with negative symptoms. 
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CHAPTER 1 
INTRODUCTION 
Negative Symptoms 
 Negative symptoms have been identified in individuals with schizophrenia since 
Kraepelin and Bleuler began classifying this mental illness (Bleuler, 1908; Kraepelin, 1919, 
reprint 1971). Kraepelin described negative symptoms as an “avolitional syndrome,” a 
“weakening of those emotional activities which permanently form the mainsprings of 
volition,” that results in “emotional dullness, failure of mental activities, loss of mastery over 
volition, of endeavor, and of ability for independent action” (Kraepelin, 1919, reprint 1971). 
The most recent categorization of negative symptoms from the NIMH-MATRICS consensus 
statement on negative symptoms, distinguishes 5 factors: alogia, blunted affect, asociality, 
avolition, and anhedonia (Kirkpatrick, Fenton, Carpenter, & Marder, 2006). Research 
suggests alogia, or a lack of speech, and blunted affect, or a diminished physical expression 
of emotions, may represent a single factor (Blanchard & Cohen, 2006). While asociality 
(little interest in relationships), avolition (lack of motivation), and anhedonia (loss of 
pleasure) may be closely related, constituting another factor. Taken together, negative 
symptoms account for a significant amount of variance in long-term functioning and 
morbidity (Bowie, Reichenberg, Patterson, Heaton, & Harvey, 2006; Buchanan, 2007; Milev, 
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Ho, Arndt, & Andreasen, 2005; Peer & Spaulding, 2007; Tek, Kirkpatrick, & Buchanan, 
2001).  
 Negative symptomatology is often categorized into two distinct classes based on 
etiology, duration and stability (Buchanan, 2007; Earnst & Kring, 1997). Primary symptoms 
describe the idiopathic symptoms inherent to the disorder of schizophrenia. These symptoms 
are thought of as enduring throughout the course of the illness, without fluctuation based on 
positive symptoms, affective symptoms, or medication status. Further categorization of 
primary symptoms specifies a subset of symptoms leading to the diagnosis of the deficit 
syndrome (Arango, Kirkpatrick, Buchanan, & Carpenter, 1998; Kirkpatrick, Buchanan, 
McKinney, Alphs, & Carpenter, 1989). Secondary negative symptoms describe the 
symptoms influenced by positive and affective symptoms, medication side-effects, or 
environmental factors. For example, a client whose anhedonia is mitigated by cognitive-
behavioral treatment of depression and whose blunted affect is improved after a change in 
antipsychotic medications would be categorized as having secondary negative symptoms. 
However, despite conceptualization of the symptoms as secondary, treatment of the 
underlying factors (e.g. medication side-effects or depression) is not always successful in 
completely eliminating secondary negative symptoms. Therefore, some researchers have 
posited describing negative symptomatology based on its resistance to treatment instead of its 
underlying factors. A label of “persistent negative symptoms” would include both primary 
symptoms and secondary negative symptoms that do not respond to treatment of underlying 
factors. These criteria are also more clinically meaningful as they define clients by their 
treatment needs (Buchanan, 2007). 
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 A review of numerous clinical and population-based studies suggests that 15-20% of 
the population of individuals diagnosed with schizophrenia have significant primary negative 
symptoms (Buchanan, 2007). No studies have assessed the prevalence rate of individuals 
with persistent negative symptoms, although this is assumed to be larger than 15-20%, as this 
category would include clients with primary symptoms and clients with treatment-resistant 
secondary negative symptoms (Buchanan, 2007). Therefore, the classification of clients with 
persistent negative symptoms helps to identify a significant subpopulation of those with 
schizophrenia who should have specific treatments designed to meet their needs. Next, I 
review etiological models of negative symptoms, as these should form the basis of 
pharmacological and psychosocial interventions. 
Theories of the etiology of negative symptoms 
Biological theories 
 Biological models suggest specific neurotransmitter pathways and areas of the brain 
with implications for both avolition and anhedonia. Biological theories of avolition 
hypothesize a modulation of frontal lobe cortical activity resulting from a depletion of striatal 
dopamine via the striato-thalamo-cortical circuit (Alexander, Crutcher, & DeLong, 1990). 
Another hypothesis places importance on mesolimbic dopamine and its role in anticipatory 
pleasure and motivation via the signaling of rewards and reward-predicting events as well as 
the processes of learning and memory (Berridge & Robinson, 2003; Smith, Becker, & Kapur, 
2005; Spangel & Weiss, 1999; Wittmann et al., 2005). Indeed, recent neuro-imaging studies 
found that decreased activity in the mesolimbic dopamine system was correlated with 
increased negative symptoms (Juckel et al., 2006; Taylor, Phan, Britton, & Liberzon, 2005). 
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Additional areas of the brain implicated in negative symptoms are the prefrontal area, 
nucleus accumbens, amygdala and ventricles (see reviews by Brown & Pluck, 2000; Earnst 
& Kring, 1997). Therefore, mesolimbic and mesocortical dopamine hypofunction seem 
linked to the core deficits of avolition and anhedonia.      
Psychological Theories 
 The literature on psychological theories of negative symptoms delineates two 
theories: one based on the importance of cognitions and the other based on the role of 
anticipatory pleasure. However, these two theories are actually congruent with each other as 
the anticipatory pleasure model retains the ability to incorporate the principles of the 
cognitive model.  This is discussed in more detail below. 
 Cognitive Model 
 The cognitive model posits that negative symptoms are the result of low expectations 
about an individual’s ability to experience pleasure, success, and acceptance (Rector, Beck, 
& Stolar, 2005; Stolar, 2004).  The individual is conceptualized as experiencing distorted 
cognitions and therefore he has a negatively biased evaluation of his ability to succeed at a 
planned behavior (avolition), the amount of pleasure he will receive from that behavior 
(anhedonia), and whether he will be accepted by others (asociality). Additionally, negative 
cognitions about the perception of limited resources affect an individual’s negative 
symptoms. For example, “I don’t have the ability to express my feelings” (blunted affect) or 
“It takes too much effort to talk” (alogia).  
 The cognitive model is conceptualized as playing an important role in both primary 
and secondary negative symptoms (Stolar, 2004). If the etiology of negative symptoms is 
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attributed to physiological disruptions (as in primary causes), then cognitions are examined 
relating to the interpretations made about these deficits. For example, an individual may 
believe that he will never be able to feel the same amount of pleasure as before the onset of 
the illness. This interpretation is conceptualized as leading to further distress and 
exacerbation of the symptom. Secondary negative symptoms caused by depression, 
demoralization, and fear of rejection are also hypothesized to have cognitive etiologies based 
on negative automatic thoughts.  
 Empirical support for this model is limited as of yet; however, some studies do 
suggest an association between beliefs and negative symptoms. First, research supports the 
hypothesis that individuals with schizophrenia endorse defeatist attitudes about their 
performance to a greater extent than a non-clinical control sample (Beck & Grant, 2008). 
Additionally, individuals with more negative symptoms tend to endorse these defeatist 
beliefs to a greater extent than those with less negative symptoms (Rector, 2004). These 
studies measured participant’s cognitions using the Dysfunctional Attitudes Scale (DAS; 
Weissman, 1978) and found that the associations between negative symptoms and defeatist 
beliefs remained significant even after controlling for depressive and positive 
symptomatology. Additionally, path-analyses supported defeatist beliefs as a significant 
mediator of the relationship between cognitive impairments and negative symptoms (Grant & 
Beck, 2008). Therefore, this research suggests that the interpretation an individual makes 
regarding their cognitive deficits plays an important role in accounting for their expression of 
negative symptoms.  
 Anticipatory Pleasure Model   
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 The anticipatory pleasure model places anhedonia as a core feature relevant to the 
etiology of negative symptoms, particularly avolition and asociality. Although all the 
negative symptoms are associated with poor prognosis and functional impairment, anhedonia 
may have a particularly strong association with impaired functioning as investigated in 
longitudinal studies (Herbener, Harrow, & Hill, 2005). Anhedonia can be divided into 
impairments in anticipatory pleasure (i.e., pleasure related to expectations regarding future 
events) and consummatory pleasure (i.e., ability to enjoy something at that moment) (Gard, 
Gard, Kring, & John, 2006; Gard, Kring, Gard, Horan, & Green, 2007; Horan, Kring, & 
Blanchard, 2006). These conceptual distinctions correspond well with research from animal 
models and neural imaging, which suggest that anticipatory pleasure is more closely 
associated with dopamine and the mesolimbic pathway while consummatory pleasure is 
related more to serotonin and opiod systems (Berridge & Robinson, 1998; Schultz, 2002; 
Wise, 2002). Anticipatory pleasure can be further divided into an emotional and cognitive 
construct, involving both an individual’s beliefs about future positive emotions and the 
immediate positive emotions garnered when considering a future experience (Gard et al., 
2007). 
 Recent research has investigated the components of anhedonia in individuals with 
schizophrenia, finding consummatory pleasure to be largely intact while deficits are found in 
anticipatory pleasure compared to non-clinical control participants (Gard et al., 2007). These 
results are consistent with the previously discussed biological research on negative symptoms 
that has found deficits in the brain correlates of anticipatory pleasure. Anticipatory pleasure 
was also found to be positively correlated with the reward motivation and social networks of 
individuals with schizophrenia (Gard et al., 2007). Additionally, anticipatory pleasure has 
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been found to relate to motivation and the pursuit of goal-directed behavior in non-clinical 
samples (Carver, 2001; Schultz, 2002). Consequently, an individual who cannot anticipate 
enjoying an activity in the future will have little incentive to work toward it (avolition). 
Likewise, an individual who cannot anticipate enjoying a social relationship in the future will 
have little interest in fostering that relationship (asociality). This theory is also supported by 
factor analytic research identifying anhedonia, avolition, and asociality loading on the same 
negative symptom factor (Blanchard & Cohen, 2006). Therefore, the anticipatory pleasure 
model of negative symptoms includes principles from the cognitive model while illustrating 
how anticipatory pleasure is critical to understanding avolition and asociality (see figure 1).  
  In summary, the etiological theories of negative symptoms place an important role on 
anticipatory pleasure. Biological research emphasizes cortical pathways associated with 
rewards while psychological research posits the importance of cognitive and emotional bases 
of pleasure, motivation, and sociality. It follows that treatments for negative symptoms 
should target cognitive and emotional deficits related to pleasure, motivation, and sociality. 
Treatment of Negative Symptoms 
Pharmacological Treatment   
 Psychopharmacological studies of the treatment of primary or persistent negative 
symptoms demonstrate mixed results using antipsychotics, glutamatergic agents, or selective 
monoamine oxidase B inhibitor (Buchanan, 2007). These inconclusive results may be due to 
a limited number of studies, small sample sizes, inconsistencies in study design, duration of 
treatment, and the level of assessment of depressive and extra-pyramidal symptoms which 
obfuscate targeted primary negative symptom outcomes (Buchanan, 2007). However, even 
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the studies demonstrating positive results of medications suggest only small to medium effect 
sizes for treating negative symptoms (Buckley & Stahl, 2007).Additionally, there seems to be 
little understanding of the mechanisms of change using psychopharmacological treatments 
for negative symptoms. Given the somewhat limited efficacy of psychopharmacological 
approaches, there is a strong need for increased research on alternative approaches to treating 
negative symptoms.  
 Previous psychosocial treatments for the negative symptoms of schizophrenia 
spectrum disorders can be divided into 3 treatment approaches: activity-based therapy, 
cognitive-behavioral therapy (CBT), and integrated therapy (IT). The results and limitations 
of studies conducted on these approaches are summarized below.  
Activity-based Therapy 
 Activity-based approaches are treatments focused on some specific behavior or 
activity done by the client or together with a therapist and/or group. The primary activity-
based treatment for negative symptoms is music therapy, defined as the therapeutic 
incorporation of any of the following components: music listening, music playing, and 
discussion of music. In a review of four randomized controlled trials incorporating group or 
individual music therapy for inpatients with schizophrenia, three of them reported data on 
negative symptoms (Gold et al., 2005). A meta-analysis of these studies demonstrated a 
standard mean difference of -0.86, indicating a large effect of music therapy on the reduction 
of negative symptoms. Recently this finding was replicated in another controlled study of 
music therapy for inpatients with schizophrenia (Ulrich, Houtmans, & Gold, 2007). Music 
therapy appears particularly beneficial because the interventions are relatively short, 
including one study that found positive results after only 1 month (Yang et al., 1998). 
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However, all of the reviewed studies only evaluated outcomes at post-treatment leaving 
questions about the long-term stability of the treatment. Also, two studies that also measured 
quality of life did not find any significant improvement resulting from music therapy over 
standard care, bringing into consideration whether the reductions in negative symptoms 
translated into client-relevant changes (Ulrich, 2004; Ulrich et al., 2007). Additionally, music 
therapy for negative symptoms has only been compared to treatment-as-usual, and therefore, 
strong conclusions cannot be drawn about the mechanism of change. Finally, music therapy 
for schizophrenia has only been tested on inpatients and results may differ in outpatient 
settings.  
 Other activity-based treatments include vocational therapy and animal-assisted 
therapy, which have only preliminary support for the treatment of negative symptoms in 
schizophrenia. Paid vocational therapy (i.e. paid employment) was found to improve 
motivation and anhedonia compared to a volunteer work condition (Bryson, Lysaker, & Bell, 
2002). However, this study employed the Heinrichs Quality of Life Scale (Heinrichs, Hanlon, 
& Carpenter, 1984), which does not represent the currently agreed upon negative symptom 
factors. In fact, the subscale used to measure motivation and anhedonia (Intrapsychic 
Foundations) also includes constructs outside the traditional negative symptom factors, such 
as empathy and sense of purpose, which may have impacted the results. Animal-assisted 
therapy teaches participants to care for and play with a domestic pet (Gammonley et al., 
1997). Animal-assisted group therapy was compared to an active control group in 20 
inpatients with schizophrenia and found to significantly improve anhedonia but not overall 
negative symptoms (Nathans-Barel, Feldman, Berger, Modai, & Silver, 2005). Therefore, 
paid vocational therapy and animal-assisted therapy are in the earliest stages of testing for the 
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treatment of negative symptoms. Music therapy appears to be the most promising line of 
treatment thus far, although more research is needed as it has never been tested in 
outpatients, with an active control group, or using long-term follow-up assessments. 
Additionally, these treatments pose potential problems as many individuals with 
schizophrenia would have difficulty accessing necessary resources such as pets and musical 
instruments upon completion of the research   
Cognitive Behavioral Therapy 
 In contrast with the limited research on activity-based treatments, a large body of 
research has been conducted on CBT for schizophrenia (although not specifically negative 
symptoms). In a meta-analysis of 23 randomized controlled trials which included a total 
sample of 1268 participants, CBT for psychosis showed a moderate effect size of .44 in favor 
of the reduction of negative symptoms (Wykes et al., 2008). However, after including only 
trials categorized as having rigorous methodology according to the Clinical Trial Assessment 
Measure (Tarrier & Wykes, 2004), reanalysis found a small effect size of .21 for reducing 
negative symptoms. Additionally, although a cognitive model for the treatment of negative 
symptoms exists, only 2 out of 34 CBT studies included in this meta-analysis were 
independently rated as primarily targeting negative symptoms (Bailer, Takats, & 
Westermeier, 2001; Daniels, 1998). The first of these studies incorporated 3 months of 
individual CBT into standard care and found significant improvements in participants’ 
negative symptoms that persisted through a 3 month follow-up assessment (Bailer et al., 
2001). Daniels (1998) approach to CBT for negative symptoms emphasized promotion of 
group process that would motivate participants to translate learned skills into their personal 
lives. However, results indicated no significant improvement in overall negative symptoms 
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or on the asociality factor. Additionally, a small CBT group pilot study targeting negative 
symptoms found no effect on negative symptoms overall, but the treatment did significantly 
reduce participants’ avolition (Johns, 2002).   
 Therefore, empirical evidence suggests that CBT has only a small effect on negative 
symptoms after considering only the most rigorous clinical trials. This small effect may be 
partly due to the limited studies that explicitly targeted negative symptoms with CBT. 
However, this may also be the result of the detrimental impact that negative symptoms have 
on social learning, which in turn, might cause a poor therapeutic response to CBT and skills 
training approaches (Hoffman & Kupper, 1997; Kopelowicz, Liberman, Mintz, & Zarate, 
1997).  
Integrated Therapy 
 The final group of treatments, IT, integrates multiple components and treatment 
approaches, such as family therapy, social skills training, CBT coping strategies, assertive 
community treatment, psychoeducation, and behavior scheduling. Studies conducted on IT 
can be divided based on the inclusion or exclusion of a priori hypotheses about the impact of 
treatment on negative symptoms.  
 IT focusing on the impact of treatment on overall symptoms found that the 
interventions did reduce negative symptoms. Specifically, one study of cognitive-behavioral 
family treatment incorporated skills training, cognitive-behavioral strategies for residual 
psychotic and non-psychotic problems, and home-based crisis management compared to 
standard care (Grawe, Falloon, Widen, & Skogvoll, 2006). This study found significant 
improvements in the negative symptoms of participants in IT compared to those in standard 
care after 2 years of treatment. Another study of family therapy included illness management 
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and psychosocial skills training and found significant reductions in negative symptoms after 
1 year of treatment compared to standard care (Valencia, Rascon, Juarez, & Murow, 2007). 
However, these long-term studies are limited in interpretation simply due to the vast 
difference in number of contact hours between the treatment and control conditions. The 
treatments also contained multiple components making it difficult to determine which led to 
reductions in negative symptoms. Finally, these studies lacked a clear theoretically informed 
rational for impacting negative symptoms.  
 IT specifically designed to target negative symptoms has had mixed results. A 2-year 
IT incorporated psychoeducation, social skills training, and optional family psychoeducation 
groups and found the intervention significantly reduced negative symptoms; however, 
unblinded raters, low interrater reliability, and differential attrition rates seriously limit the 
conclusions of the study (Thorup et al., 2005). A small pilot study targeting negative 
symptoms used a coping-oriented group therapy to integrate psychoeducation for the 
participant and family members, coping skills, and behavior scheduling (Andres, Pfammatter, 
Garst, Teschner, & Brenner, 2000). This 24-session long IT had an effect size reduction of 
1.4 for negative symptoms compared to 0.8 for Supportive Therapy. However, the small 
sample size (n= 32) permits only preliminary conclusions about the intervention’s efficacy. 
A large randomized clinical trial investigated a treatment called Training of Self-
management Skills for Negative Symptoms (TSSN), which was designed to target negative 
symptoms using behavior scheduling, social skills training, and motivational techniques 
(Vauth et al., 2005). However, even when TSSN was combined with vocational 
rehabilitation, the study found no significant effects on negative symptoms. Therefore, IT has 
some initial support for its efficacy, however, methodological flaws and a lack of theoretical 
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rationale for some of these studies make interpretations difficult.  Additionally, the most 
critical feature of these IT are their long-term nature, making them difficult to implement for 
individuals with low motivation who are less likely to complete a lengthy treatment course.   
 In sum, psychopharmacological, CBT and IT approaches have initial support for the 
treatment of negative symptoms; however, studies conducted with methodological rigor 
suggest only small effect sizes. These findings also indicate the potential shortcomings of the 
biological and cognitive theories of negative symptoms. There does appear to be some 
support for the treatment of negative symptoms using activity-based therapies, particularly 
music therapy. However, the feasibility of this approach to treatment may be limited because 
the requisite musical instruments may not be readily available to clients after the study ends, 
thereby limiting its long-term efficacy. Therefore, other psychosocial interventions for 
negative symptoms should be explored, particularly those that teach coping skills which will 
continue to foster recovery after the treatment period. Also, activity-based and IT currently 
lack a theoretical rationale for their impact on negative symptoms. Thus, it is essential that 
any psychosocial intervention have a sound theory on which treatment is based, particularly 
one that could provide a framework addressing how anticipatory pleasure may impact 
negative symptoms. One such theory is the broaden-and-build theory of positive emotions.  
Broaden-and-build theory of positive emotions 
 A substantial body of empirical evidence within the normal population indicates that 
negative emotions narrow an individual’s action tendencies, which may have been 
evolutionarily adaptive for survival (e.g. anger or fear leads to fight or flight). The broaden-
and-build theory of positive emotions takes a complementary position and posits that positive 
emotions broaden an individual’s momentary thought-action repertoire; the accrual over time 
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of these broadened moments then leads an individual to think and behave in a way that builds 
personal resources (Fredrickson, 1998, 2001). This building of physical, social, intellectual, 
and psychological resources then provided an evolutionary advantage by increasing chances 
of survival. Additionally, the accrual of these resources is durable, unlike the transient nature 
of positive emotions, and leads to increased satisfaction in life. This challenges distinctions 
between hedonic well-being, or the mere enhancement of positive emotions, and eudemonic 
well-being, defined as the striving toward one’s potential and purpose in life (Ryan & Deci, 
2001). These forms of well-being may be related where hedonic well-being leads to 
eudemonic well-being through the accumulation of resources.  
 This theory holds special importance because of its potential applicability to 
treatment of the negative symptoms of schizophrenia. If positive emotions broaden thought-
action repertoires and build resources, then some of these resources could include increased 
sociality, motivation, and anticipatory pleasure, which are core deficits associated with the 
negative symptoms of schizophrenia. In turn, this theory indicates that improvements in these 
resources affect life satisfaction, which is likely to be low in individuals with negative 
symptoms given their poor prognosis and impaired functioning.  
 The broaden-and-build theory is backed by a strong empirical foundation of research 
demonstrating that positive emotions broaden the thought-action repertoire. For example, 
studies show that individuals experiencing positive emotions demonstrate thinking that is 
notably unusual, flexible, creative, integrative, open to information and efficient (see review 
by Isen, 2000) as well as having a broadened repertoire of desired actions (Fredrickson & 
Branigan, 2005). Likewise, prospective correlational studies suggest that individuals 
experiencing more frequent positive emotions build psychological resources such as 
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optimism and resilience (Cohn, Fredrickson, Brown, Mikels, & Conway, 2008; Fredrickson, 
Tugade, Waugh, & Larkin, 2003) and social resources such as improved quality of 
relationships (Gable, Gonzaga, & Strachman, 2006; Gable, Reis, Impett, & Asher, 2004; 
Waugh & Fredrickson, 2006). However, the association between broadened thought-action 
repertoires and built personal resources has only limited and indirect support, partly due to 
the difficult nature of finding an intervention that consistently induces positive emotions 
(Fredrickson, Cohn, Coffey, Pek, & Finkel, 2008). This phenomenon of adaptation describes 
the tendency for an individual to return to a baseline set-point of well-being once novelty has 
subsided and would likely affect laboratory-based tasks such as watching pleasant films 
(Diener, Lucas, & Scollon, 2006).  
 The “build” hypothesis was recently tested when Frederickson and colleagues (2008) 
identified an approach that improves positive emotions and is relatively immune from 
hedonic treadmill effects: meditation. Unlike laboratory tasks, meditation is active and 
personalized, and insights gained from it can be applied to a variety of situations and life 
domains. In a wait-list control design using a non-clinical sample of 141 participants, the 
broaden-and-build theory of positive emotions was tested using loving-kindness meditation 
(LKM; Salzberg, 1995), a type of concentration meditation focused on directing warm, 
compassionate feelings to self and others (Fredrickson et al., 2008). The study found that the 
meditation group led to more positive emotions over the course of the 6 weeks than the 
control group, a necessary step to testing the build hypothesis. The amount of time 
participants spent meditating outside of the group session was also a significant predictor of 
increased positive emotions as well as positive emotions during social interactions. The study 
was unable to assess broadening due to the inherent difficulties of measuring this construct 
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outside of a lab setting. However, results did show that an increase in positive emotions was 
significantly associated with a building of resources including mindfulness, anticipatory 
pleasure, hope, environmental mastery, self-acceptance, purpose in life, social support and 
relationships, and lower physical illness symptoms. The final part of the theory was also 
supported demonstrating that positive emotions alone did not lead to increased life 
satisfaction but instead the changes in personal resources mediated increased satisfaction 
with life.  
There have been four other empirical studies of LKM to date, which all found results 
consistent with the broaden-and-build theory of positive emotions. First, a study of LKM was 
conducted using a non-clinical sample where participants were asked to either engage in 
several minutes of LKM or a closely matched control task (Hutcherson et al., 2008). The 
study found that participants practicing LKM had a significant increase in mood compared to 
the control condition. Most importantly, LKM participants also had significant increases in 
positivity towards others on an explicit and implicit level compared to the control group. 
Additionally, changes in positive mood were found to account for a significant amount of 
variance in explicit positivity towards others, suggesting support for the broaden-and-build 
theory of positive emotions. Second, a study of brain activity during LKM was conducted 
using fMRI with novices and “experts” in meditation, defined as practicing Buddhist 
meditation for over 10,000 hours (Lutz, Brefczynski-Lewis, Johnstone, & Davidson, 2008). 
The study analyzed limbic areas typically associated with empathic responses to others while 
participants were practicing or not practicing LKM. The study concurrently examined neural 
activity during emotional human vocalizations (positive, neutral, or distressed) designed to 
generate empathy in participants. Results suggested a significant 3-way interaction where the 
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greatest limbic response (and hypothesized empathic response) resulted from expert 
meditators hearing distressed vocalizations during LKM. This study suggests that LKM may 
alter areas of the brain associated with empathy towards others, which could play a role in 
the building of relationships. In fact, it may be that empathy is one of the psychological 
resources built by the accumulation of positive emotions induced during LKM. The third 
study of LKM piloted the intervention in a small group of chronic pain patients and found 
that LKM significantly reduced pain and distress compared to a standard care control group 
(Carson et al., 2005). Most recently a study of college students compared LKM alone, 
mindfulness alone, LKM & mindfulness (combination), and a control group (Sears & Kraus, 
2009). This study found that the combination group yielded the greatest improvements in 
anxiety, negative mood, and hope. Additionally, across treatment group, a reduction in 
cognitive distortions was found to be a significant mediator of these outcomes. In sum, these 
additional studies of LKM improved participants’ mood, attitudes towards others, and hope 
while also reducing physical pain and psychological distress. These outcomes can be 
considered built resources according to the broaden-and-build theory of positive emotions.  
These studies have implications for the treatment of negative symptoms and the 
enhancement of psychological recovery of individuals with persistent negative symptoms. 
The aforementioned research found that LKM improved anticipatory pleasure and social 
connectedness in non-clinical samples (Fredrickson et al., 2008). Therefore, LKM may have 
promise in ameliorating the specific deficits of anhedonia and asociality found in individuals 
with negative symptoms via the mechanism of increasing positive emotions. Additionally, 
LKM was found to improve participants’ hope, self-acceptance, environmental mastery and 
purpose in life. These constructs are synonymous with how individuals with severe mental 
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illness describe “psychological recovery”, according to a review of qualitative research 
(Andresen, Oades, & Caputi, 2003). Conducting LKM in a group setting may also provide 
the additional benefits of therapeutic group process factors, such as universality, acceptance 
and interpersonal learning (Yalom, 1995). In fact, research supports the relationship between 
group process factors and long-term improvements in functioning in individuals with severe 
mental illness (Yalom, 1995). However, before testing this intervention in a clinical 
population, it is necessary to review any existing research on meditation in general and its 
application to the treatment of schizophrenia.  
Meditation 
 Meditation has been defined as the act of inward contemplation and the intermediate 
state between attention to a stimulus and complete absorption in it (Taylor, 1999). Many 
different practices and techniques exist within mediation; basic categorization distinguishes 
meditations based on concentration or mindfulness, although there is a significant amount of 
overlap (Ivanovski & Malhi, 2007). Concentration meditation is conceptualized as the 
focusing of one’s attention onto a specific stimulus, such as a thought or image, to enhance 
clarity and awareness. Concentration meditations include various forms of yoga, 
Transcendental meditation, and LKM.  Mindfulness meditation is an expansion of awareness 
to become non-judgmentally aware of one’s internal experience and includes Zen and 
Vipassana meditation (see review by Ivanovski & Malhi, 2007).  
Growing evidence suggests that both concentration and mindfulness meditation are 
associated with a variety of clinical benefits, including anxiety and stress regulation, 
reduction of chronic pain, and management of medical illnesses (for reviews, see Baer, 2003; 
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Delmonte, 1985; Kabat-Zinn, 2003a). Mindfulness meditation has been incorporated into 
several therapeutic approaches including mindfulness-based stress reduction (MBSR; Kabat-
Zinn, 2003b), mindfulness-based cognitive therapy (MBCT; Teasdale, 2004), acceptance and 
commitment therapy (ACT; Hayes, Strosahl, & Wilson, 1999); and dialectical behavior 
therapy (DBT; Scheel, 2000).  
Meditation in Psychotic Disorders 
Within meditation, less work has been conducted with individuals with psychotic 
disorders particularly when using concentration meditations.  However, pilot studies suggest 
that meditation has promise in this clinical population. Specifically, in an uncontrolled trial, a 
6-week mindfulness meditation group intervention was associated with an increase in well-
being and improvement in functioning among 11 individuals with schizophrenia spectrum 
disorders (Chadwick, Taylor, & Abba, 2005). In a qualitative study, 8 inpatients on an acute 
unit attended mindfulness groups and reported feelings of relaxation and peace, as well as a 
desire to continue practicing mindfulness after discharge (York, 2007). In another study of 
113 psychiatric inpatients, one session of Hatha yoga, a concentration meditation, was found 
to significantly reduce negative emotions in participants immediately after practice (Lavey et 
al., 2005). In addition, many individuals with severe mental illnesses such as schizophrenia 
have interest in and practice meditation.  In a sample of 157 adults with severe mental 
illnesses (25% schizophrenia), meditation was the second most commonly used alternative 
health care practice (Russinova, Wewiorski, & Cash, 2002). Finally, one of the interventions 
that incorporates mindfulness-based practices (i.e., ACT) has been shown to reduce distress 
associated with psychotic symptoms and hospitalizations among inpatients with psychotic 
disorders relative to treatment as usual (Bach & Hayes, 2002; Gaudiano & Herbert, 2006).  
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Nonetheless, the literature is cautious about the parameters of using meditation with 
individuals diagnosed with a psychotic disorder due to several case studies of meditation 
precipitating psychotic episodes (see review in Yorston, 2001) . However, these isolated case 
studies almost always involved extreme amounts of meditation while being deprived of food 
and sleep; none resulted from clinical studies. 
Thus, LKM has initial support for its ability to generate positive emotions in the 
general population, which builds the resources of anticipatory pleasure and social 
connectedness that are specifically lacking in individuals with persistent negative symptoms. 
Additionally, studies of meditation with individuals with severe mental illness show it has 
been utilized as an alternative medicine practice suggesting its adequate treatment 
satisfaction in this population. Existing research also supports improvements in well-being, 
functioning, positive emotions, and reduction in negative emotions in psychiatric inpatients 
who participated in meditation groups. Therefore, LKM needs to be further investigated as a 
potential treatment for the amelioration of negative symptoms of schizophrenia and the 
improvement of psychological recovery. 
Overview of Current Study and Hypotheses 
 The current study is an initial evaluation of LKM regarding its feasibility and 
potential clinical utility for individuals with schizophrenia with persistent negative 
symptoms. An uncontrolled clinical trial of LKM was conducted to evaluate clinical and 
psychosocial benefits, feasibility, tolerability, and qualitative client impressions of the 
treatment. Figure 2 illustrates the conceptualization of LKM on the hypothesized outcomes.  
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 Primary hypotheses for the pilot study of LKM are: 
1) LKM will be well-tolerated, favorably received, and feasible to implement in a group 
setting (based on client feedback, attendance and attrition rate, and time spent 
meditating outside of the group). 
2) LKM will be associated with improvements (i.e., within-group effects) with respect to 
the primary outcome of positive affect, measured directly before and after each LKM 
session as well as from baseline to follow-up.  
3) LKM will be associated with improvements (i.e., within-group effects) with respect to 
the primary outcome of negative symptoms, specifically the anhedonia, avolition, and 
asociality factor. Additionally within anhedonia, LKM is hypothesized to be 
associated with specific improvements in anticipatory pleasure.  
4) LKM will be associated with improvements (i.e., within-group effects) with respect to 
the secondary outcome of psychological recovery as defined by subscales of 
psychological well-being, hope, and satisfaction with life. 
The ultimate aim of the pilot study was to investigate the feasibility and client-tolerance 
of the treatment, which provides the foundation for a randomized controlled trial (RCT) of 
LKM to offer a more stringent test of its efficacy.  This stepwise process is consistent with 
recent recommendations for the development of evidence-based treatments (Mueser & 
Drake, 2005).  The methodology of the current pilot study is described in detail in the 
following section. 
  
 
CHAPTER 2 
METHODS 
Participants 
A total of 18 individuals with schizophrenia-spectrum disorders were recruited from 
three different settings: 1. UNC-Chapel Hill, School of Medicine, Schizophrenia Treatment 
and Evaluation Program (STEP) 2. UNC-Chapel Hill, School of Medicine, Outreach and 
Support Intervention Services (OASIS) program 3. Caramore Community, Inc., an assisted 
living program for severe mental illness based in Carrboro, NC. To be eligible for the study, 
a potential participant must have met the following criteria: 1.) met full DSM-IV diagnostic 
criteria for a schizophrenia-spectrum disorder based on chart review; 2) was between the 
ages of 18-60; 3) have an IQ greater than 80 as measured by the Wechsler Abbreviated 
Scales for Intelligence (WASI; The Psychological Corporation, 1999); 4) did not meet 
current criteria for substance dependence based on chart review/physician interview; 5) 
demonstrated prominent negative symptoms based on a score of moderate on one domain of 
the Negative Symptom Rating Scale (Kring, 2008); 6) had little experience with LKM; 7) did 
not have current or prior traumatic brain injury, stroke, seizure disorder, or any other 
neurological disease/condition based on chart review/physician interview; and 8) did not 
suffer from prominent medication side effects that may have resulted in persistent secondary 
negative symptoms as based on physician interview. Demographic characteristics of the 
sample are summarized in Table 1. 
  
 
23 
Measures 
Screening measures 
 Wechsler Abbreviated Scales for Intelligence (WASI; The Psychological 
Corporation, 1999). This structured clinical assessment is used to assess intelligence and has 
well-established validity and reliability with a population of individuals diagnosed with 
schizophrenia. The WASI was used to rule out any individuals who did not possess the 
cognitive abilities to follow the instructions of the meditation facilitator (IQ < 80). The two 
subtests that were used to calculate the participant’s full-scale IQ are Matrix Reasoning and 
Vocabulary.  
 Demographic Questionnaire (developed for the study). This self-report questionnaire 
was used to assess the participant’s age, current medications, education, gender, psychiatric 
history, ethnic background, and previous experience with meditation.   
Psychiatric Symptoms 
 Negative Symptom Rating Scale (NSRS; Kring, 2008). This semi-structured interview 
provides a 7-point anchor system on 23 items to enable a clinical interviewer to assess the 
severity of five domains of negative symptoms reflected in the recent NIMH-MATRICS 
consensus statement: anhedonia, asociality, avolition, blunted affect, and alogia (Kirkpatrick 
et al., 2006). A major theme of the NSRS distinguishing it from existing measures is its focus 
on the experiential aspects of negative symptoms that are considered to be at the conceptual 
core of the emotional, social, and motivational deficits that define negative symptoms. The 
NSRS also avoids confounding experiential deficits in hedonic capacity or drive with 
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behavioral success or functional outcomes. For example, an individual who has no friends 
due to lack of social skill or opportunity but who would like to be in a close relationship will 
not receive a similar score on the asociality subscale with someone who has no friends but 
also prefers to be alone. Psychometric analyses in this pilot study found that the subscales 
had adequate internal reliability except for the avolition subscale, which was not used alone 
in further analyses (NSRS total=.73; anhedonia=.87; asociality=.56; avolition=.07; blunted 
affect=.80; alogia=.95). The internal consistency of the asociality subscale was borderline 
acceptable and should be interpreted cautiously.  
 Brief Symptom Inventory (BSI; Derogatis, 1993; Derogatis & Spencer, 1982). This 
53-item self-report instrument is designed to measure psychological symptoms and distress 
and has excellent psychometric properties in both clinical and nonclinical populations 
(Derogatis, 1993); (Derogatis & Spencer, 1982). Respondents choose from a 5-point scale 
(0=not at all, 4= extremely) that represents the extent to which each problem or complaint 
has caused distress in the last month. Nine symptom constructs are obtained from the 
measure as well as three global indices of distress. The Positive Symptom Total represents the 
number of symptoms endorsed The Positive Symptom Distress Index represents the 
respondent’s severity of distress; and the Global Severity Index includes information about 
both number of symptoms and distress (cronbach’s alpha=.96). 
 Calgary Depression Scale (CDS; Addington, Addington, Maticka-Tyndale, & Joyce, 
1992). This 9-item structured interview is designed to measure depressive symptoms with 
each item using a 4 point scale anchored by descriptors. The CDS has excellent psychometric 
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properties for schizophrenia spectrum disorders and a cronbach’s alpha of .71 in the current 
study.   
Emotions 
 Modified Differential Emotions Scale (mDES; for original see Izard, 1977, for 
modified see Fredrickson et al., 2003). Participants rated the frequency with which they felt 
each of 26 emotions during the past two weeks on a 5-point scale (0= not at all, 4= most of 
the time). The positive emotion subscale consists of 13 items (amused, awe, excitement, 
grateful, hopeful, in control, inspired, joyful, interested, love, proud, satisfied, serene) and the 
negative emotion subscale consists of 13 items (angry, ashamed, bored, contempt, disgust, 
embarrassed, guilty, hatred, rejected, sad, scared, stressed, tired). The internal consistency of the 
subscales in the current study was .87 (positive emotions) and .92 (negative emotions).  
 Weekly Mood Scale (developed for the study). This 2-item self-report questionnaire 
uses a 4 point Likert-type scale to assess the intensity of pleasant and unpleasant emotions 
the participant is feeling at the moment. This measure was administered immediately prior to 
and after each LKM session.  
 Day Reconstruction Method (DRM; Kahneman, Krueger, Schkade, Schwarz, & 
Stone, 2004). The DRM assesses emotion experiences episode-by-episode during a specific 
day. With the help of the interviewer, participants divided their afternoon prior to the 
assessment into a continuous series of episodes and provided a descriptive label for each 
episode. We allowed a maximum of 10 episodes from lunch to dinner. Thereafter and 
working individually, participants revisited each labeled episode to provide intensity ratings 
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from not at all (0) to extremely (9) for the positive and negative emotion adjectives from the 
mDES (Frederickson et al., 2003). The 
DRM methodology capitalizes on the strengths of time-budget measurement and experience 
sampling, which are less influenced by the recall bias of retrospective surveys.  
 Informant Questionnaire (developed for the study). Participants in the second cohort 
were asked to invite up to 5 people with whom they interact regularly to participate as 
informants in the study. Online invitations, consent forms, and access to the questionnaire 
were sent to these informants at baseline, post-treatment and 3 month follow-up assessments. 
Informants indicated the number of interactions they had with the LKM participant the day 
prior to completing the questionnaire as well as the length of the most significant interaction. 
Informants completed several likert-type questions rating the closeness and overall quality of 
the relationship. Finally, informants completed the mDES from the perspective of the 
participant, rating the frequency that he or she felt each positive and negative emotion during 
the previous 2 weeks.  
Cognitive Resources 
 Temporal Experience of Pleasure Scale (TEPS; Gard et al., 2006). Anticipatory 
pleasure was rated by participants using the 10-item anticipatory pleasure subscale of the 
TEPS. This subscale assesses the amount of pleasure an individual derives from looking 
forward to experiences. For example, “When ordering something off the menu, I imagine 
how good it will taste.” Participants then rated how true this statement is for them on a 6 
point Likert-type scale (0= very false for me, 6= very true for me). The TEPS has excellent 
estimates of reliability and has convergent validity for use with individuals with 
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schizophrenia (Gard et al., 2007). The internal consistency of the subscales in the current 
study were .71 (anticipatory pleasure) and .80 (consummatory pleasure).   
 Savoring Beliefs Inventory-anticipating (SBI; Bryant, 2003). The SBI assessed the 
participants’ tendency to enjoy pleasant experiences. The current study used only one of the 
subscales from the measure: participants’ ability to pleasurably anticipate experiences 
beforehand (Savoring the Future). Participants indicated agreement on a 7-point scale with 8 
items, including "I feel a joy of anticipation when I think about upcoming good things.” The 
measure was found to have adequate reliability and validity in the general population 
(Bryant, 2003) and cronbach’s alpha of .84 in the current study. 
 Weekly Pleasure Scale (developed for the study). Prior to each weekly LKM session, 
participants completed a 3-item self-report measure assessing their pleasure during the 
previous week resulting from interacting with people, recreational activities, and physical 
sensations. After each weekly LKM session, participants completed the same 3-item self-
report measure pertaining to expectations of pleasure in the upcoming week. Participants 
indicated ratings on a 7-point scale ranging from no pleasure to strong pleasure. Cronbach’s 
alpha was .76 for the past pleasure subscale and .86 for the future subscale.  
Psychological/Social Resources & Recovery 
Psychological Well Being (PWB; Ryff, 1989). The PWB is a self-report measure of 
well-being and consists of six subscales with a total of 54 items (medium length form based 
on full length 120 item scale). Participants indicated agreement on a 6-point scale (1 = 
strongly disagree, 6 = strongly agree) for items from the following 6 subscales: Personal 
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Growth, with items like “For me, life has been a continuous process of learning, changing, 
and growth"; Environmental Mastery, with items like “I often feel overwhelmed by my 
responsibilities” (reverse scored); Autonomy, with items like “I am not afraid to voice my 
opinions, even when they are in opposition to the opinions of most people”; Self-Acceptance, 
with items like “I like most parts of my personality”; Purpose in Life, with items like “My 
daily activities often seem trivial and unimportant to me” (reverse scored); and Positive 
Relations with Others, with items like “I know that I can trust my friends, and they know 
they can trust me.” Several of the PWB subscales, including Purpose in Life, Environmental 
Mastery, and Self-Acceptance, closely mirror the definition of “psychological recovery” as 
put forth by those experiencing severe mental illness (Andresen et al., 2003); therefore these 
scales from the PWB are considered a measure of psychological recovery. The internal 
consistency of these scales was acceptable in the current study except Personal Growth, 
which was removed from further analyses (Personal Growth=.27; Environmental 
Mastery=.81; Autonomy=.92; Self-acceptance=.88; Purpose in Life=.84; Positive 
Relations=.70; Total=.94).  
Trait Hope Scale (THS; Snyder et al., 1991). The THS is a self-report scale that 
measures agency thinking and pathways thinking, the two cognitive components of hope 
theory. Participants used a four-point scale to indicate agreement or disagreement (1 = 
definitely false, 4 = definitely true) with 8 items divided between two subscales: Agency 
Thinking (belief that one has been / will be personally able to achieve one’s goals), including 
“I meet the goals I set for myself” and Pathways Thinking (belief that there are multiple ways 
to achieve one’s goals), including “There are lots of ways around any problem.” The THS 
was found to have good convergent and discriminant validity, internal reliability and support 
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for the two-factor structure in the general population (Snyder, Ilardi, Michael, & Cheavens, 
2000). The internal consistency of this scale was borderline acceptable in the current study 
and as such, only the total score was used in further analyses (Agency=.66; Pathways=.66; 
Total=.72). 
 Satisfaction with Life Scale (SWLS; Diener, Emmons, Larsen, & Griffin, 1985). The 
SWLS is a 5-item scale that assessed participants' global satisfaction with their lives and 
circumstances. Participants indicated agreement on a 7-point scale with each item, including 
"So far I have gotten the important things I want in life." The single factor SWLS has good 
reliability and validity in the general population (Arrindell, Meeuwesen, & Huyse, 1991; 
Pavot & Diener, 1993) and has initial support for adequate psychometric properties with 
individuals with schizophrenia (Wu & Wu, 2008). In the current study, the internal 
consistency of this scale was .82.  
Treatment Feasibility & Adherence 
 Attendance Tracking Form (developed for the study). Weekly attendance was 
recorded for each participant.  
 Meditation Practice Questionnaire (developed for the study). Prior to each weekly 
LKM session, participants were asked to complete a 3-item self-report measure assessing 
their LKM practice during the previous week (e.g. number of times they utilized the study 
CD to do LKM, number of different days they practiced, and average number of minutes 
practiced each day). These questions were also asked on the one- and two-month follow-up 
phone calls. 
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 Stakeholder Feedback Form (developed for the study). This 10-item measure is 
divided into a quantitative and qualitative section that assessed the participants’ satisfaction 
with the intervention as well as its perceived benefits. 6 quantitative self-report questions 
were rated using a 3-point Likert-type scale and 4 open-ended qualitative questions were 
asked by the clinical interviewer. Similar feedback questionnaires have been successfully 
used in other treatment development studies for individuals with schizophrenia (e.g. Penn, 
Roberts, Combs, & Sterne, 2007; Waldheter et al., 2008). 
Intervention 
 LKM is a technique used to increase feelings of warmth and caring for self and others 
(Salzberg, 1995; Wallace & Shapiro, 2006). Similar to other meditation practices, LKM 
involves quiet contemplation, often with eyes closed or in a non-focused state and an initial 
attending to the present moment. Then participants directed their attention to their heart 
region and contemplated a person for whom they already feel warm, tender, and 
compassionate feelings (e.g., their child, a close loved one, a pet) or a situation when they 
felt warm feelings. They were then asked to extend these warm feelings to themselves. Often 
phrases such as “May I be safe” or “May I be at peace” were internally verbalized to help 
generate these feelings. As the practice continues, they were asked to radiate these warm, 
tender, and compassionate feelings to others; first to a few people they know well, then to all 
their friends and family; then to all people with whom they have a connection, and finally to 
all people and creatures of the earth. Although phrases and images may be repeated, these 
were used to generate positive emotions which are the intended focus of the participants’ 
attention. The participants attended 6 one hour weekly sessions for 6 weeks and a review 
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session that took place 6 weeks after the final session. Each LKM session was conducted by 
a Masters-level licensed meditation facilitator, Mary Brantley, who has practiced for over 25 
years and recently coauthored a book about LKM (Brantley & Hanauer, 2008). 
The weekly group sessions incorporated 3 major components: discussion, skills 
teaching, and practice. At the beginning of each session the participants were encouraged to 
discuss something they learned from doing the meditation or a perceived benefit of the 
meditation. Problems, challenges, or questions about the practice were then addressed as a 
group with advice given to meet presented needs and reinforcement for positive aspects of 
the practice. Next, a mindfulness activity was taught and practiced, such as mindful eating, 
walking, listening or body movement. These practices were done to strengthen the 
participant’s ability to concentrate in the present moment. This rationale was given to 
participants to help them see the ultimate goal of strengthening focus on loving-kindness. A 
novel aspect of loving-kindness meditation was then taught by the group leader who often 
used selected readings from books. Finally, the group facilitator led the participants in 5-10 
minute LKM practices during the session, gently reminding participants to non-judgmentally 
redirect their attention to the feeling of loving-kindness when attention wandered. 
Participants were then encouraged to practice LKM formally by daily listening to a CD of the 
meditation, which contains 3 different sessions ranging from 15-25 minutes. Additionally, 
informal practice was suggested throughout the day for durations as short as a few minutes at 
prescribed times or when distressing situations arise. 
Procedures 
The current pilot study utilized a pre-post design without a comparison control group 
for an initial examination of the feasibility and potential clinical benefits of LKM for 
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individuals who have schizophrenia with persistent negative symptoms. This design was 
chosen over a quasi-experimental group or randomized control as this is a recommended first 
step in determining the feasibility of the intervention (Mueser & Drake, 2005). In addition, 
researchers disagree about the need for a control group when the outcomes being targeted are 
typically stable over time, such as persistent negative symptoms (Mueser & Drake, 2005).  
Two different groups of 9 participants attended the LKM group weekly for 6 sessions 
lasting one hour each as well as a 6 week follow-up booster session. Participants were 
assessed by a trained rater at baseline, post-treatment, and 3-month follow-up on a number of 
outcomes previously described. Participants also received a one- and two-month follow-up 
phone call to ask about their meditation practice and serve as a reminder. All participants 
continued to receive usual medical care for their disorder throughout the intervention, 
including antipsychotic medication. 
  
 
CHAPTER 3 
RESULTS 
Overview of Data Analyses 
First, relevant data were examined to evaluate the feasibility and acceptability of the 
intervention. Qualitative feedback from participants was informally analyzed for themes 
relevant to any perceived benefits or dislikes of the intervention. Next, quantitative analyses 
(i.e. paired samples t-tests) were conducted with an emphasis on within-group effect sizes, 
and clinical significance for changes between: 1) baseline and post-test 2) baseline and three-
month follow-up. This approach to analyses is consistent with previous treatment 
development research in severe mental illness (Mueser et al., 2007; Waldheter et al., 2008). 
However, statistical inferences should be made with great caution given the number of t-tests 
calculated and the associated inflation of type I error (as well as the small sample size). 
 Effect sizes were calculated by examining the magnitude of pre-post change 
correcting for the pooled standard deviation and the correlation of the outcome at both time 
points (Dunlap, Cortina, Vaslow & Burke, 1996; Cohen, 1988). Cohen’s d value was 
evaluated according to standard criteria: small (d = .20), medium (d = .50), and large (d = 
.80).   
Clinically significant change was determined using criteria refined by Jacobson and 
Truax (1991), which currently is the most commonly used method of calculating clinical 
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significance and has a more meaningful interpretation than statistical significance 
(McGlinchey, Atkins, & Jacobson, 2002). Clinical significance was calculated for each 
individual participant taking into account the standard deviation and test-retest reliability of 
the measure in normative samples. However, when this method was unable to be completed 
for a particular measure (e.g. limited normative data for the NSRS), then clinically significant 
change was evaluated according to criteria typically used in schizophrenia research (e.g., 
20% reduction or improvement; Cather, Otto, Yovel, Mueser, & Goff, 2005).  
Preliminary Analyses 
The following results are based on the intent-to-treat sample, which included both 
treatment completers and non-completers (n=18). This is considered a more conservative 
estimate of the effects of the intervention given that the treatment non-completers received 
only a small dose of the intervention (i.e. 2 sessions). Independent sample t-tests comparing 
completers and non-completers found no differences on baseline variables or demographics 
(although this is based on a comparison of 16 versus 2 participants). Additionally, analyses of 
treatment completers alone (n=16) did not alter the pattern of results found when using the 
intent-to-treat sample. Finally, the two intervention cohorts did not differ significantly from 
one another on any demographic or baseline outcome variables. Therefore, they were 
combined for all subsequent analyses. 
Analyses of the 3 month follow-up assessment are based on the first cohort only 
(n=9) as the second cohort is scheduled for that assessment at the end of June 2009. Results 
presented are based on a last observation carried forward procedure, due to one participant 
relocating out of the country prior to the 3 month assessment (e.g. Mueser et al., 2007).   
Feasibility and Acceptability 
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 Hypothesis 1 predicted that LKM would be feasible and acceptable based on 
attendance, attrition, and participant feedback. Figure 3 is a CONSORT diagram that 
summarizes the participant flow throughout the study. Eighteen participants received the 
intervention with 16 participants defined as treatment completers (i.e. attended 4 or more 
sessions) and 2 participants defined as treatment non-completers (i.e. attended fewer than 3 
sessions). The intent-to-treat sample had an 84% attendance rate with an average of 5.06 
sessions attended (SD = 1.35 range = 2-6). Treatment completers had an attendance rate of 
91% with an average of 5.44 sessions attended (SD = .82; range = 4-6). Both treatment non-
completers attended 2 sessions. During the 6 week intervention, treatment completers 
listened to an average of 1.6 tracks of the meditation audio CD per week. Treatment 
completers also practiced the meditation formally or informally for a mean of 3.73 days per 
week (SD=1.43) at an average of 19.06 minutes per practice (SD=14.55).  
Treatment satisfaction scores in Table 2 suggest excellent acceptability of the 
intervention. Positive ratings were provided on all items including the ease of the meditation 
practices, perceived utility of LKM, and enjoyment of the group. Ratings were also positive 
for the perception that LKM helped participants look forward to being with people and enjoy 
things in life; however, most ratings for these items were not in the extreme positive 
category.  
Feedback from the qualitative section of the Stakeholder Feedback Form provided a 
more personal perspective on what was enjoyed about the group and the perceived benefits of 
the intervention (although please note that formal qualitative analyses were not conducted). 
Participants most commonly reported enjoying a sense of peace and relaxation as a result of 
the LKM group and the meditation (n=10). Also, almost half of the participants reported 
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enjoying the social aspects of being in a group, including feeling supported, encouraged, and 
less distracted while meditating (n=8). Several participants also reported enjoying being able 
to attend to the present moment (n=4). The majority of participants reported experiencing 
some positive change in their life as a result of the intervention (n=15). Almost every 
participant reported unique changes including feeling more “peaceful”, “happy,” “empathic,” 
“able to access feelings of loving-kindness,” “alert,” and “able to focus.”  
An obstacle reported by 3 participants was the experience of having difficulty or not 
agreeing with sending loving-kindness to all people of the world. Other challenges to using 
the meditation were finding time (n=2), remembering to practice (n=2), and difficulties 
concentrating (n=2). Three participants suggested making the intervention longer by 
increasing the session duration or the number of sessions.  
 The two treatment non-completers were both in the second cohort and each attended 
only two sessions (sessions 3 & 4). During the post-treatment assessment, the first participant 
indicated that he had wanted a group therapy where he would receive help for his 
individualized difficulties. He reported that he did not see any way that the meditation 
practice would assist him personally. The second participant was asked by the researcher to 
discontinue attendance due to his disruptive behavior in group. During the sessions, this 
participant often spoke negatively about his impressions of the meditation, stated that he was 
not practicing according to the instructions, and was oppositional towards the group 
facilitator. During the post-treatment assessment, the participant discussed enjoying the 
meditation but feeling paranoid as a result of the group being located in his mental health 
clinic. He also felt disrespected by the group facilitator, believing that the facilitator was 
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treating everyone at a low functioning level, and that he was being accused of using drugs or 
alcohol (which the Director of his clinic also suspected). 
Clinical Outcomes 
Table 3 summarizes the pre-post means and standard deviations, effect sizes, and 
statistically significant changes based on paired sample t-tests (note: Ns are different for 
post-test and 3-month follow up assessments, as the former is based on both cohorts one and 
two, while the latter is based only on cohort one). Table 4 displays the percentage of 
participants who experienced a clinically significant change on each primary clinical 
outcome.  
Hypothesis 2 stated that participants should show increased positive affect at post-
treatment and 3 month follow-up assessments following LKM. Analyses were based on 4 
measures: 1. mDES (i.e. frequency of emotions during the previous 2 weeks) 2. DRM (i.e. 
intensity of emotions during the previous afternoon) 3. Informant mDES (i.e. informant 
ratings of the estimated emotions of the participants during the previous 2 weeks) and 4. 
Weekly Mood Scale (i.e. mood ratings before and after each LKM session).  
The results of both the mDES and DRM revealed a large positive within-group effect 
size for participants’ positive emotions at post-treatment and the 3 month follow-up. The 
results of the Informant mDES showed a medium positive within-group effect size for 
participants’ positive emotions at the post-treatment assessment. Figure 4 illustrates the 
participants’ mood ratings associated with each LKM session. The mean pleasant mood 
immediately before each LKM session was 2.59 (SD=.69) and after each LKM session was 
2.99 (SD=.73).  An ordered logistics regression found no statistically significant main effect 
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on positive mood for impact of session (i.e. pre or post), time (i.e. differences across the 6 
sessions), or the interaction of the two variables. However, odds ratios found that an LKM 
participant was 2.84 times more likely to rate an increased pleasant mood after a LKM 
session. Analyses of clinical significance indicated that close to half of the participants 
experienced a 20% increase in positive emotions on the mDES and DRM at the post-
treatment assessment. Overall, these data indicate an increase in participants’ positive 
emotions after the treatment and persisting at the 3 month follow-up.    
Hypothesis 3 stated that participants should experience decreased negative symptoms 
at post-treatment and 3 month follow-up assessments following LKM. Therefore, with-in 
group paired t-tests were conducted on the NSRS total score and on the planned subscales of 
“anhedonia” and “asociality.” Large negative within-group effect sizes (which are in the 
expected direction) were found for total negative symptoms and anhedonia with reductions 
persisting at the 3 month follow-up. A medium negative within-group effect size was found 
for asociality at post-treatment and a small negative within-group effect size at the 3 month 
follow-up. Over two-thirds of the participants experienced a clinically significant reduction 
in anhedonia and total negative symptoms at the post-treatment assessment, while almost half 
of the participants experienced a clinically significant reduction in asociality.   
Likewise, hypothesis 3 predicted increases in pleasure, specifically anticipatory 
pleasure as measured by the TEPS, SBI, and Weekly Pleasure Scale following LKM. With-in 
group paired t-tests conducted on the TEPS revealed no significant changes in participants’ 
anticipatory pleasure at post-treatment and 3 month follow-up. However, the SBI anticipating 
subscale yielded a large positive effect size at the post-treatment with improvements 
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persisting at the 3 month follow-up assessment. The TEPS consummatory pleasure subscale 
also yielded a large positive effect size at the post-treatment and 3 month follow-up. In order 
to understand these mixed results, Table 5 presents the correlations among the anhedonia-
related measures at baseline. The results indicate that the NSRS anhedonia scale and SBI 
anticipatory scale are significantly associated with one another. The TEPS subscales are 
significantly related to one another, but not with either the NSRS anhedonia scale or SBI 
anticipatory scale. These results suggest that the TEPS and SBI are measuring somewhat 
separate constructs. 
Analyses of clinical significance indicate that approximately 20% of the sample 
experienced a 20% improvement on the TEPS consummatory pleasure subscale and the SBI 
anticipating subscale.  On the Weekly Pleasure Questionnaire, mean pleasure experienced the 
week prior to each session was reported as 12.51 (SD=3.26) and mean pleasure expected 
from the upcoming week was 12.73 (SD=3.19).  An ordered logistics regression found no 
statistically significant main effect of time (i.e. pre-post) or session (i.e. 1-6) on past or future 
weekly pleasure ratings. Overall, these data suggest improvements in negative symptoms 
after the treatment and persisting at the 3 month follow-up. 
Hypothesis 4 stated that participants would experience improvements in 
psychological recovery at post-treatment and 3 month follow-up assessments following 
LKM. Analyses of the self-acceptance and environmental mastery subscales of the PWB 
revealed large positive effect sizes at post-treatment, with medium positive effect sizes on 
both subscales at the 3 month follow-up. The purpose in life subscale had mixed findings 
with a small positive effect size at post-treatment and a small to medium negative effect size 
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at the 3 month assessment. Therefore, participants’ purpose in life increased immediately 
after the intervention but decreased after 3 months relative to baseline. Analyses of clinical 
significance indicate that approximately 20% of the sample experienced a 20% improvement 
on these target subscales of psychological well-being.  
 Analyses of participants’ total hope score (i.e. THS) yielded a medium positive effect 
size at the post-treatment assessment which persisted at the 3 month follow-up assessment. 
Fifty percent of the participants experienced a clinically significant improvement in hope at 
the post-treatment assessment. Finally, a large positive effect size was found for participants’ 
satisfaction with life (i.e. SWLS) at post-treatment and a medium positive effect size at the 3 
month follow-up assessment. Ten percent of the sample experienced a clinically significant 
improvement in satisfaction with life at the post-treatment assessment, based on the Jacobson 
& Truax (1991) method; 50% of the sample experienced a 20% increase on this measure.  
Exploratory Analyses 
Exploratory analyses conducted on secondary clinical outcomes are summarized in 
table 6. A small positive effect size was found for the positive symptom total subscale of the 
BSI, indicating an increase in the number of symptoms observed at the post-treatment and 3 
month follow-up assessments. However, a medium negative effect size was found for the 
symptom distress subscale of the BSI, indicating reductions in distress associated with 
symptoms at post-treatment and 3 month follow-up assessments. A medium to large negative 
effect size was found on the CDS, indicating a reduction in depression at the post-treatment 
assessment; however, only a small negative effect size was found at the 3 month follow-up. 
Analyses of additional subscales of the NSRS yielded large negative effect sizes for blunted 
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affect and alogia, suggesting reductions in these negative symptoms at the 3 month follow-
up.  
Six participants from the second cohort had informants (i.e. family or friends) 
complete a questionnaire at baseline and post-treatment. This questionnaire asked the 
informants about their interactions with the study participant the day prior to completing the 
questionnaire. The number of informants for each participant ranged from 1 to 3, with a 
median of 2. A majority of informants were female (60%) and family members of 
participants (80%) with a mean age of 51.27 years (SD=14.14). Table 6 summarizes the 
results of that questionnaire. Findings demonstrate a large positive effect size for the number 
of interactions occurring over a one day period. Also, a small positive effect size was found 
for the length of the most salient conversation over a one day period. No statistically 
significant changes are found on the informants’ ratings of the quality of the relationship with 
study participants. Taken together, the results suggest that informants did notice an 
improvement in the number and duration of participants’ conversations but no changes in the 
closeness of the relationship.  
Exploratory bivariate correlations were computed between change scores on clinical 
outcomes from baseline to post-treatment so as to examine potential relationships consistent 
with the broaden-and-build theory of positive emotions (see Table 7). Exploratory 
hypotheses were that 1.) time spent meditating outside of sessions would be positively 
correlated with increased positive emotions 2.) increased positive emotions would be related 
to decreased negative symptoms and increased psychological recovery. Inconsistent with 
hypothesis 1, the amount of time participants spent meditating outside of the LKM sessions 
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was not significantly associated with changes in positive emotions from baseline to post-
treatment. However, consistent with hypothesis 2, increases in positive emotions (i.e. on the 
mDES) were significantly associated with reductions in target negative symptoms 
(correlations ranged from -.58 to -.79), and increases on scales representing psychological 
recovery (.47 to .77). Changes in positive emotions were not significantly associated with 
changes on anticipatory or consummatory pleasure. Given the small N, and the fact that these 
are not mediation analyses, these findings should be interpreted cautiously. 
  
 
CHAPTER 4 
DISCUSSION 
 In accordance with treatment development procedures, this uncontrolled pilot study 
aimed to evaluate the feasibility and acceptability of LKM with individuals with persistent 
negative symptoms of schizophrenia. Consistent with our hypotheses, LKM was found to be 
well tolerated with high attendance and low attrition. Next, it was predicted that participants 
would experience an increase in positive emotions, reduction in negative symptoms, and 
increase in psychological recovery. Initial results supported these hypotheses and suggest that 
LKM may be a promising treatment for this clinical population. Findings are discussed in 
further detail below.  
Feasibility and Acceptability 
 LKM was associated with a high level of interest and attendance. Over 85% of the 
referrals were interested in receiving more information about the group. Even when 
individuals who did not answer the phone or return voice messages are included, the 
remaining 2/3 of the individuals referred for the study were interested in participating. 
Similarly, an attendance rate of 91% for treatment completers with 11% attrition rate is 
considered well-tolerated and a necessary condition for further testing of an intervention 
(Mueser & Drake, 2005). For comparison, a pilot study of group mindfulness meditation for 
individuals with schizophrenia (also 6 sessions) had a similar attendance rate (86%) but a 
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higher attrition rate (27%) (Lavey et al., 2005). Further empirical studies of meditation 
interventions may find high rates of attendance, which is consistent with previous research 
establishing high rates of self-reported alternative medicine practice within the psychiatric 
population (Russinova et al., 2002).  
Self-report of LKM practice outside of session also suggests treatment engagement 
given that participants practiced regularly (i.e. almost 4 days per week). However, self-report 
of LKM practice should be interpreted cautiously due to experimenter demand effects. Future 
studies may include more ecologically valid measures of practice such as Computerized 
Ecological Momentary Assessment (EMAc; Granholm, Loh, Swendsen, 2008). This is 
particularly relevant for LKM as results suggest that participants often practiced informally 
(i.e. various times throughout the day without the CD), which may be more difficult to recall 
than formal practices (i.e. prescribed times using the CD).  
 Intervention feedback provided by participants supports the acceptability and 
perceived utility of LKM.  All participants reported finding the group useful and a majority 
stated that it was very enjoyable. Reports of increased relaxation as well as improved 
concentration and awareness of the present moment are consistent with qualitative findings 
from a pilot study of group mindfulness for psychiatric inpatients (York, 2007). Additionally, 
almost half of the sample reported enjoyment from the group alliance, which may be an 
important factor given the positive relationship between group alliance and attendance rate 
(Johnson, Penn, Bauer, Meyer, & Evans, 2008). Future research should also include 
quantitative measures of relaxation, mindfulness, and group alliance to measure changes in 
these outcomes as well as test them as mediators.  
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Clinical Outcomes 
 While these outcome data must be interpreted with great caution, results were 
consistent with hypotheses based on previous research and on the broaden-and-build theory. 
LKM was associated with an increase in participants’ positive emotions from baseline to 
post-treatment assessments, which is consistent with the studies of LKM in non-psychiatric 
populations (Fredrickson et al., 2008; Hutcherson et al., 2008). The results of this study are 
particularly strong given the significant findings from three different measures of positive 
emotions, one of which was rated by informants. Further testing of the intervention should 
investigate whether the persistence in increased positive emotions after the intervention is 
due to continued LKM practice by participants (maintenance effect). Longitudinal analyses 
of the Frederickson et al. (2008) study of LKM found that participants who continued to 
practice meditation at least occasionally reported more positive emotions at a one year 
follow-up than non-continuers (Cohn & Fredrickson, 2009). It may also be that 6 sessions of 
the intervention was a sufficient “dose” of treatment to initiate the “upward spiral” effects of 
positive emotions. This would be consistent with previous research indicating positive 
emotions predict increases in future positive emotions, partly through positive coping and 
interpersonal trust (Burns, Brown, Sachs-Ericsson, Plant, Curtis, Fredrickson, et al., 2008; 
Fredrickson & Joiner, 2002).  
 No significant changes were found on the Weekly Mood Scale; however, inspection 
of the results suggests a ceiling effect given the skewed data. Future testing should involve 
expanding this likert-type scale’s response choices from 4 to 10, potentially increasing the 
measure’s variability.  
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 LKM was also associated with a large decrease in participants’ total negative 
symptoms and anhedonia with smaller reductions in asociality. These findings are consistent 
with previous research demonstrating that LKM improved social support and positivity 
towards others in non-clinical samples (Fredrickson et al., 2008; Hutcherson et al., 2008). 
Data collected from participant informants suggest increased social interactions both in 
quantity and duration after the 6 week intervention, which is consistent with the observed 
decrease in asociality. Although there was not an improvement in the quality of the 
relationship with informants, 6 weeks may be a limited amount of time to observe noticeable 
changes in this domain. This finding is also consistent with recent longitudinal analyses of an 
LKM intervention (Fredrickson et al., 2008), which found that participants who continued 
their meditation practice did not experience closer relationships with informants compared to 
those who discontinued practice after the intervention (Cohn & Fredrickson, 2009). Further 
research should explore whether reductions in asociality are limited to increased interactions 
with others but not necessarily increased closeness. Additionally, reductions in alogia and 
blunted affect were found at both post-treatment assessments, which would be expected 
given the changes in other negative symptoms and the inter-relationships amongst these 
factors (Wolf, 2006).  Analyses specific to avolition could not be conducted due to low 
reliability and further testing is therefore warranted.  
 As part of the previous hypothesis, it was expected that changes in anhedonia would 
be specific to anticipatory pleasure and not consummatory pleasure. This hypothesis was 
partially supported as participants’ scores on the SBI anticipating subscale significantly 
improved after LKM, consistent with previous research within a non-psychiatric sample 
(Fredrickson et al., 2008). This improvement would be expected according to the broaden-
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and-build theory given the increase in positive emotions, which builds resources such as 
anticipatory pleasure. 
   However, no changes were found on the TEPS anticipatory pleasure subscale, which 
has been validated in this clinical population. There are some possible explanations for the 
inconsistency in findings across these measures. First, the TEPS was developed to be a trait 
measure of pleasure and therefore items may not be sensitive to changes in pleasure over a 
shorter period of time. This differs from the SBI, which is a state measure of people’s beliefs 
about their ability to savor future events. In fact, the author of the SBI recommends its use 
for evaluating therapeutic interventions like LKM, which are designed to enhance savoring 
(Bryant, 2003). Second, the TEPS intentionally assesses only a single domain of pleasure 
(i.e. physical), whereas the SBI assesses overall pleasure regardless of domain. Therefore, it 
is possible that participants’ experienced improvements in other domains of anticipatory 
pleasure beyond physical pleasure (i.e. social, recreational, occupational), which may also 
account for the lack of correlation between the measures. 
 No changes were found on the Weekly Pleasure Scale, which was not consistent with 
our hypotheses. However, the Weekly Pleasure Scale was developed for this study as an 
adaptation from the NSRS anhedonia subscale and therefore further testing needs to be 
conducted to establish its basic psychometric properties.  
 Finally, it should be noted that participants did experience a significant improvement 
on the TEPS consummatory pleasure subscale, which was not predicted. This may be due to 
regression to the mean, given that participants in this pilot study yielded a baseline mean 
below that of the sample used for validating the TEPS with schizophrenia-spectrum disorders 
(Gard et al., 2007). It is also possible that LKM builds the potential to experience pleasure in 
  
 
48 
the moment for those who are particularly lacking in that capacity. Further testing should 
explore this finding with a larger sample and through cross validation with the SBI present 
savoring subscale.   
 LKM was associated with an increase in participants’ psychological recovery, which 
is consistent with the research on LKM in non-psychiatric samples. Participants’ 
improvement on the Psychological Well Being (PWB) Scale indicated that they were more 
accepting of themselves, which includes strengths and limitations, and more in control of 
their life routine and responsibilities. These findings are consistent with previous qualitative 
research that psychiatric inpatients applied mindfulness to regulate their life, become self-
reliant, and decrease self-judgments (York, 2007). Participants in the current pilot study were 
also more hopeful and satisfied with their life after the intervention; results consistent with 
previous research in non-clinical samples (Fredrickson et al., 2008; Sears & Kraus, 2009). 
Further research should assess whether these changes are due to the building of positive 
emotions, which would be consistent with previous research in non-psychiatric samples and 
the broaden-and-build theory.  
 Inconsistent with hypotheses, participants did not experience improvement in purpose 
in life. It should be noted that although the measures of psychological recovery had adequate 
internal reliability in the current study, none of the subscales have been validated for use with 
schizophrenia-spectrum disorders. Therefore, further research needs to first establish the 
validity of the Purpose in Life subscale before using it in further testing of LKM for this 
population. Visual inspection of the baseline means for the PWB subscales also shows that 
participants had elevated levels of purpose in life as compared to the other subscales. 
Therefore, non-significant changes on the Purpose in Life subscale may be the result of 
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unintentionally selecting a sample of participants who were content with their purpose in life 
and not seeking changes in that domain (one of the limitations of a small sample). Normative 
data on this subscale from the medium form length of the PWB is limited, which prevents 
further exploration of this unexpected finding.  
 Exploratory analyses revealed patterns of findings consistent with the primary 
outcomes and with previous research. Participants experienced a slight increase in symptoms 
of psychopathology; however, these symptoms were associated with less distress at both 
post-treatment assessments. Previous research on another mindfulness-based intervention 
(i.e. ACT) has demonstrated similar findings in schizophrenia, which the authors posit are 
due to enhanced awareness but reduced emotional attachment to symptoms (Guadiano & 
Herbert, 2006). Participants also reported less symptoms of depression after the intervention, 
which is consistent with previous research on LKM with a non-psychiatric sample 
(Frederickson et al., 2008). It should be noted that this reduction in depression is not likely 
accounted for by changes in anhedonia, as these are found to be distinguishable factors in 
schizophrenia (Horan et al., 2006). Instead, future research should replicate the findings of 
Fredrickson et al. (2008), which supported the theory that increased positive emotions led to 
decreased depression partly through building of resources.  
 Finally, exploratory correlations computed between outcome change scores were 
generally consistent with the broaden-and-build theory but should not be interpreted as 
inferring support for the theory. Increased positive emotions from baseline to post-test were 
found to be associated with decreased negative symptoms and increased psychological 
recovery, which is consistent with research on LKM using a non-clinical sample 
(Fredrickson et al., 2008).  
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 However, there were two unexpected results based on the exploratory correlations. 
First, longer length of time spent meditating outside of session was not associated with 
increased positive emotions at the post-treatment assessment. This finding may be due to the 
averaging of meditation practice across all 6 weeks, which does not capture changes in 
practice over time. Indeed, Fredrickson et al. (2008) found a dose-response relationship 
between the practice of LKM and the experience of positive emotions which tripled from the 
initial weeks to the final week of the intervention. Second, positive emotions were not 
significantly correlated with anticipatory or consummatory pleasure on the TEPS. This 
finding is consistent with research on the validation of the TEPS (Gard et al., 2006). 
However, changes in positive emotions were also not significantly correlated with the SBI. 
This finding is inconsistent with previous research demonstrating that LKM increased 
positive emotions, which then led to improvements in anticipatory pleasure (Frederickson et 
al., 2008).  However, this previous research used meditational models compared to the 
current study’s simple correlations. Indeed, other research on the SBI has demonstrated only 
a modest correlation between happiness intensity and anticipatory pleasure (Bryant, 2003).  
Study Limitations and Future Directions 
 The current pilot study had several limitations that should be noted. First, the 
uncontrolled study design precludes any causal inferences about the efficacy of LKM. One 
possible confounding variable is season, given that both cohorts began the intervention 
during the winter and finished at the start of spring. Previous research has demonstrated a 
relationship between warmer weather and improved mood that is unique to spring, likely 
because individuals have been deprived of good weather during the winter (Keller, 
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Fredrickson, Ybarra, Cote, Johnson, Mikels, et al., 2005). Second, the small sample size 
precluded meditational analyses to test causal hypotheses and limited the power to detect 
changes in some variables (e.g. Weekly Mood Scale). Third, the primary measure of negative 
symptoms was a semi-structured interview administered by a researcher who was not blind to 
the study hypotheses, which has been identified as a key source in over-estimating the effects 
of a treatment (Tarrier & Wykes, 2004). And fourth, self-report measures, which constitute 
the majority of the assessment battery, are susceptible to demand effects, social desirability, 
and recall bias (Larsen & Fredrickson, 1999).  
Changes to the intervention should also be considered based on qualitative feedback 
provided by participants. A few participants expressed difficulty or disagreement with 
sending loving-kindness to all people of the world. Some participants reported being 
confused as to how this would help others while other participants did not believe that all 
people deserved to receive loving-kindness, depending on their moral standing. It is 
recommended that future applications of the intervention involve more discussion of the 
rationale for this aspect of LKM. It can be clarified that sending loving-kindness to all people 
of the world is not intended to alter those people but instead to help the person practicing 
LKM. A few participants also suggested lengthening the intervention; however, the majority 
seemed content with 6 hour-long sessions and future testing will likely keep this consistent 
with the current pilot study.  
In closing, this study showed that LKM is a feasible and acceptable intervention for 
individuals with persistent negative symptoms of schizophrenia-spectrum disorders. It is 
hoped that upcoming research will support the preliminary clinical benefits found in this pilot 
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study and that LKM will become an effective tool to help individuals with schizophrenia on 
their journey of recovery.  
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Table 1  
Baseline characteristics of sample for LKM pilot study (n = 18) 
 
Gender (n) 
 Males      15 
 Females     3 
Ethnicity (n) 
 Caucasian     13 
 African-American    2 
 Bi-racial     3     
  
Age (years)a      29.39 ± 10.24 
Education (years) a      14.17 ± 2.04 
IQ (WASI) a      112.00 ± 14.47 
Unemployed (n)     10      
Marital status (n) 
 Never married     17 
 Divorced     1 
Primary diagnosis (n)  
 Schizophrenia     8    
 Schizoaffective    6 
 Psychosis NOS/Schizophreniform  4     
  
Time since onset of illness (years)a   4.78 ± 6.03 
 
a
 M ± SD.   
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Table 2 
 
Feedback on LKM from intent-to-treat sample (n=18)  
 
 
Note. a All items were rated from 1-3, with 1 indicating most negative response (e.g., “not at 
all easy,” “not at all useful,” and 3 indicating most positive response (e.g., “very easy to 
follow,” “very useful”) 
 
 
 Response a 
                
 
Item 
 “1” 
n (% of respondents) 
 “2” 
n (% of respondents) 
 “3” 
n (% of respondents) 
 
How easy was it 
to follow the 
meditation 
exercises? 
1 6% 7 39% 10 56% 
How much did 
you enjoy this 
group? 
0 0% 6 33% 12 67% 
How useful was 
the group to 
you? 
0 0% 10 56% 8 44% 
Were the 
meditation 
exercises 
respectful to you 
as an individual?  
0 0% 10 56% 8 44% 
How much did 
the group help 
you in looking 
forward to being 
with people?  
2 11% 12 67% 4 22% 
How much did 
the group help 
you enjoy things 
in your life? 
0 0% 13 72% 5 28% 
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Table 3 
Primary Outcomes: Intent-to-treat sample (Pre-test & Post-test: n=18; 3 month follow-up: n=9) 
Variable Pre-test M (SD)       Post-test M (SD)          d  3 month follow-up 
a
       
M (SD)               d 
mDES: Positive 1.50 (.59)     1.78 (.66)*                  .78        1.85 (.85)          .89 
DRM: Positive b 2.05 (.50)     2.37 (.88)*                  .96        2.39 (.80)          1.26 
Informants’ mDES:    
     Positive c     
   2.40 (.48)    2.52 (.86)                 .50       N/A 
NSRS Total   60.83 (11.17)    44.89 (15.40)*           1.68        50.33 (12.84)*  1.50 
     Anhedonia 20.94 (5.88)    14.11 (4.81)*             1.88        16.00 (4.5)*      2.40 
     Asociality    7.78 (2.96)     6.67 (3.14)                  .53        7.67 (3.43)        .23 
TEPS: Anticipatory    4.01 (.67)     4.03 (.79)                    .06        3.92 (.88)          .09 
     Consummatory    3.84 (.99)     4.30 (.75)*                  .93        4.18 (1.09)        .77 
SBI: Future    4.39 (8.48)     8.11 (8.44)*                .75        9.44 (8.66)        .83 
PWB: Self-Acceptance  25.67 (8.40)    30.56 (10.67)*             .80        30.44 (11.19)    .50 
      Environ. Mastery  29.56 (8.05)    33.17 (9.22)*             1.04        34.22 (8.54)      .54 
      Purpose in Life  32.33 (9.22)    33.11 (8.88)                 .20        34.44 (7.56)     -.37 
THS Total d  20.59 (3.86)    21.79 (5.13)                 .47        22.56 (4.45)      .59 
SWLS d  13.94 (6.03)        16.82 (6.42)*                .86        18.78 (7.17)      .63 
Note. A positive effect size indicates improvement, and a negative effect size indicates 
deterioration.   
 
* statistically significant change on paired samples t-test (p<.05)  
a effect size and statistical significance based on means for first cohort (n=9; LOCF for 1 
participant) 
b
 n = 16 (measure intentionally not given to 2 participants due to fatigue from the assessment 
battery) 
c
 n = 6 (average of informant responses for 6 participants from second cohort) 
d n = 17 (measure unintentionally not given to one participant) 
 
mDES= Modified Differential Emotions Scale; DRM= Day Reconstruction Method; NSRS= 
Negative Symptom Rating Scale; TEPS= Temporal Experience of Pleasure Scale; SBI= 
Savoring Beliefs Inventory; PWB= Psychological Well-Being Scale; THS= Trait Hope 
Scale; SWLS= Satisfaction with Life Scale 
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Table 4 
Number of participants with clinically significant change on primary outcome variables at 
the post-treatment assessment (n=18) 
 
Note.  Equations from Jacobson & Truax (1991) were used to calculate clinical significance when 
sufficient normative data were available. Additionally, participants with a 20% change on the 
measures are presented indicating improvement on those measures (per convention, e.g., Cather et al., 
2005).  
a
 n = 16 (measure intentionally not given to 2 participants due to fatigue from the assessment battery) 
b
 n = 17 (measure unintentionally not given to one participant) 
 
mDES= Modified Differential Emotions Scale; DRM= Day Reconstruction Method; NSRS= 
Negative Symptom Rating Scale; TEPS= Temporal Experience of Pleasure Scale; SBI= Savoring 
Beliefs Inventory; PWB= Psychological Well-Being Scale; THS= Trait Hope Scale; SWLS= 
Satisfaction with Life Scale
 Equation based (% of sample)      20% change (% of sample)            
mDES Positive Emotions N/A         9 (50%)                             
DRM  Positive Emotions a N/A         7 (44%)                               
NSRS Total N/A         12 (67%)                             
     Anhedonia N/A         13 (72%)                             
     Asociality N/A         8 (44%)                               
TEPS: Anticipatory 5 (28%)         1 (6%)                                  
     Consummatory 6 (33%)         4 (22%)                               
SBI Future 2 (11%)         3 (17%)                               
PWB Self Acceptance N/A         4 (22%)                                                               
    Environmental Mastery  N/A         3 (17%)                                                             
    Purpose in Life N/A         5 (28%)                               
THS b 9 (53%)         5 (29%)  
SWLS b 2 (12%)         8 (47%)                             
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Table 5 
 
Bivariate correlations computed among measures of anhedonia at baseline  
 
 
TEPS   
Anticipatory 
Pleasure 
TEPS 
Consummatory 
Pleasure 
SBI Anticipating 
NSRS 
Anhedonia 
-.21 -.40 -.54* 
SBI Anticipating .11 .28  
TEPS 
Consummatory 
Pleasure 
.61*   
* p<.05 
 
NSRS= Negative Symptom Rating Scale; TEPS= Temporal Experience of Pleasure Scale; 
SBI= Savouring Beliefs Inventory 
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Table 6 
Exploratory Outcomes: Intent-to-treat sample (Pre-test & Post-test: n=18; 3 month follow-
up: n=9) 
Variable Pre-test M (SD) Post-test M (SD)  d  3 month follow-up (n=9)
b
    
M (SD)           d 
BSI: Symptom Severity 1.00 (.68) 1.00 (.75)          -.01   .96 (.58)             -.20 
     Symptom Total 24.56 (13.06) 26.89 (13.34)    -.27   27.00 (13.20)     -.33 
     Symptom Distress 2.01 (.61) 1.74 (.72)*         .69   1.76 (.44)            .47 
CDS 5.83 (4.00) 4.61 (3.97)*       .70   4.11 (4.57)          .15 
NSRS: Blunted Affect 15.00 (5.45) 11.11 (5.91)*     .99   11.78 (4.55)      1.18 
       Alogia 5.67 (3.33) 4.44 (3.58)         .64   5.56 (3.21)          .93 
Informants: # of        
       Interactionsa 
6.17 (7.33) 7.38 (8.86)       1.22   N/A 
       Interaction length 
          (mins.)a 
18.38 (21.1) 24.17 (21.79)     .27   N/A 
       Quality of  
           relationshipa 
3.97 (.52) 3.93 (1.06)        -.11   N/A 
 
Note. A positive effect size indicates improvement, and a negative effect size indicates 
deterioration.   
 
* statistically significant change on paired samples t-test (p<.05) 
a
 n = 6 (average of informant responses for 6 participants from second cohort)  
b
 effect size and statistical significance based on means for first cohort (n=9; LOCF for 1 
participant) 
 
BSI= Brief Symptom Inventory; CDS= Calgary Depression Scale; NSRS= Negative 
Symptom Rating Scale mDES= Modified Differential Emotions Scale 
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Table 7 
 
Bivariate correlations computed between change scores of positive emotions and changes 
scores of primary outcomes (baseline to post-treatment assessment; n=18) 
 
 mDES Positive Emotions 
Minutes spent meditating outside 
of session (averaged across week) 
.08 
NSRS Total .79** 
      Anhedonia .58* 
      Asociality .65** 
TEPS: Anticipatory Pleasure .09 
      Consummatory Pleasure .32 
SBI: Future .11 
PWB: Self Acceptance .47* 
      Environmental Mastery .48* 
      Purpose in Life .77** 
THS a .71** 
SWLS a .73** 
Note. A positive correlation indicates positive emotions are associated with improvement, 
and a negative correlation indicates positive emotions are associated with deterioration.   
 
* p<.05 
** p<.01 
a
 n = 17 (measure unintentionally not given to one participant) 
 
mDES= Modified Differential Emotions Scale; NSRS= Negative Symptom Rating Scale; 
TEPS= Temporal Experience of Pleasure Scale; SBI= Savoring Beliefs Inventory; PWB= 
Psychological Well-Being Scale; THS= Trait Hope Scale; SWLS= Satisfaction with Life 
Scale 
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Figure 1. Anticipatory pleasure model of negative symptoms. 
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Figure 2. The broaden-and-build model of positive emotions as applied to the effects of LKM 
on the improvements in negative symptoms and psychological recovery of individuals 
with schizophrenia (modified from Fredrickson et al., 2008).  
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Figure 3. CONSORT diagram.  
 
Total Referrals (n=63) 
From Mental Health Clinicians (n= 59)  
From Flier/Newsletter (n= 4) 
     Assessed through phone screen (n= 30) 
Ineligible after phone screening (n= 6) 
Minimal negative symptoms (n= 5)   
Highly disorganized (n=1) 
Baseline assessment & allocated to treatment 
(n= 18) 
Excluded (n= 33) 
Not answering phone  
(n= 13) 
Timing/transportation 
     conflict (n= 10) 
Not interested (n= 8) 
Age criteria (n= 2) 
     Assessed through baseline screening (n= 24) 
Ineligible after baseline screening (n= 6) 
Minimal negative symptoms (n= 6) 
Treatment completers (at least 4 sessions) (n= 16) 
Treatment non-completers (n =2) 
Post-treatment assessment (n= 18) 
 
3-month follow-up assessment (n= 8) 
Attrition due to relocation (n= 1) 
Upcoming assessments (end of June) (n= 9) 
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Figure 4. Mean weekly pleasant mood ratings before and after each LKM session  
 
  
 
64 
 
 
 
REFERENCES 
Addington, D., Addington, J., Maticka-Tyndale, E., & Joyce, J. (1992). Reliability and 
validity of a depression scale for schizophrenics. Schizophrenia Research, 6, 201-208. 
 
Alexander, G., Crutcher, M., & DeLong, M. (1990). Basal ganglia-thalamocortical circuits: 
Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. 
Progress in Brain Research, 85, 119-146. 
 
Andres, K., Pfammatter, M., Garst, F., Teschner, C., & Brenner, H. D. (2000). Effects of a 
coping-orientated group therapy for schizophrenia and schizoaffective patients: A 
pilot study. Acta Psychiatrica Scandinavica, 101(4), 318-322. 
 
Andresen, R., Oades, L., & Caputi, P. (2003). The experience of recovery from 
schizophrenia: Towards an empirically validated stage model. Australian and New 
Zealand Journal of Psychiatry, 37(5), 586-594. 
 
Arango, C., Kirkpatrick, B., Buchanan, R. W., & Carpenter, W. T., Jr. (1998). The deficit 
syndrome: A domain of schizophrenia. Actas Luso-Espanolas de Neurologia, 
Psiquiatria y Ciencias Afines, 26(3), 180-186. 
 
Arrindell, W. A., Meeuwesen, L., & Huyse, F. J. (1991). The satisfaction with life scale 
(SWLS): Psychometric properties in a non-psychiatric medical outpatients sample. 
Personality and Individual Differences, 12, 117–123. 
 
Bach, P., & Hayes, S. C. (2002). The use of acceptance and commitment therapy to prevent 
the rehospitalization of psychotic patients: A randomized controlled trial. Journal of 
Consulting and Clinical Psychology, 70(5), 1129-1139. 
 
Baer, R. A. (2003). Mindfulness training as a clinical intervention: A conceptual and 
empirical review. Clinical Psychology: Science and Practice, 10, 125–143. 
 
Bailer, J., Takats, I., & Westermeier, C. (2001). Efficacy of individualized cognitive-
behavioral therapy for schizophrenic patients with negative symptoms and social 
disabilities: A controlled trial. Zeitschrift fur Klinische Psychologie und 
Psychotherapie, 30, 268-278. 
 
Beck, A. T & Grant, P. M. (2008). Negative self-defeating attitudes: Factors that influence 
everyday impairment in individuals with schizophrenia.  American Journal of 
Psychiatry, 165 (6), 772.  
  
 
65 
 
Berridge, K., & Robinson, T. (2003). Parsing reward. Trends in Neurosciences, 26, 507-513. 
 
Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic 
impact, reward learning, or incentive salience? Brain research. Brain Research 
Reviews, 28 (3), 309-369. 
 
Blanchard, J. J., & Cohen, A. S. (2006). The structure of negative symptoms within 
schizophrenia: Implications for assessment. Schizophrenia Bulletin, 32(2), 238-245. 
 
Bleuler, E. (1908). Dementia praecox, or the group of schizophrenias. New York, NY: 
International Universities Press. 
 
Bowie, C. R., Reichenberg, A., Patterson, T. L., Heaton, R. K., & Harvey, P. D. (2006). 
Determinants of real-world functional performance in schizophrenia subjects: 
Correlations with cognition, functional capacity, and symptoms. American Journal of 
Psychiatry, 163(3), 418-425. 
 
Brantley, M., & Hanauer, T. (2008). The gift of loving-kindness: 100 meditations on 
compassion, generosity, and forgiveness. Oakland, CA: New Harbinger Publications. 
 
Brown, R. G., & Pluck, G. (2000). Negative symptoms: The 'pathology' of motivation and 
goal-directed behaviour. Trends in Neurosciences, 23(9), 412-417. 
 
Bryant, F. B. (2003). Savoring beliefs inventory (SBI): A scale for measuring beliefs about 
savouring. Journal of Mental Health, 12(2), 175-196. 
 
Bryson, G., Lysaker, P., & Bell, M. (2002). Quality of life benefits of paid work activity in 
schizophrenia. Schizophrenia Bulletin, 28(2), 249-257. 
 
Buchanan, R. W. (2007). Persistent negative symptoms in schizophrenia: An overview. 
Schizophrenia Bulletin, 33(4), 1013-1022. 
 
Buckley, P. F., & Stahl, S. M. (2007). Pharmacological treatment of negative symptoms of 
schizophrenia: Therapeutic opportunity or cul-de-sac? Acta Psychiatrica 
Scandinavica, 115(2), 93-100. 
 
Burns, A.B., Brown, J.S., Sachs-Ericsson, N., Plant, E.A., Curtis, J.T., Fredrickson, B.L., & 
Joiner, T.E. (2008). Upward spirals of positive emotion and coping: Replication, 
extension, and initial exploration of neurochemical substrates. Personality and 
Individuals Differences, 44, 360-370. 
 
Carson, J. W., Keefe, F. J., Lynch, T. R., Carson, K. M., Goli, V., Fras, A. M., et al. (2005). 
Loving-kindness meditation for chronic low back pain: Results from a pilot trial. 
Journal of Holistic Nursing, 23(3), 287-304. 
  
 
66 
 
Carver, C. S. (2001). Affect and the functional bases of behavior: On the dimensional 
structure of affective experience. Personality and Social Psychology Review, 5 (4), 
345-356. 
 
Cather, C. P., D. L., Otto, M. W., Yovel, I., Mueser, K. T., & Goff, D. C. (2005). A pilot 
study of functional cognitive behavioral therapy (fCBT) for schizophrenia. 
Schizophrenia Research, 74, 201-209. 
 
Chadwick, P., Taylor, K. N., & Abba, N. (2005). Mindfulness groups for people with 
psychosis. Behavioural and Cognitive Psychotherapy, 33(3), 351-359. 
 
Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: 
Erlbaum. 
 
Cohn, M. A., Fredrickson, B. L., Brown, S. L., Mikels, J. A., & Conway, A. (2008). 
Happiness unpacked: Positive emotions increase life satisfaction by building 
resilience. Manuscript under review. 
 
Cohn, M. A. & Fredrickson, B. L. (2009). Continued benefits from loving-kindness 
meditation, one year later. Manuscript in preparation. 
 
Corporation, T. P. (1999). Manual for the wechsler abbreviated scale of intelligence. San 
Antonio, TX: The Psychological Corporation. 
 
Daniels, L. (1998). A group cognitive-behavioral and process-oriented approach to treating 
the social impairment and negative symptoms associated with chronic mental illness. 
Journal of Psychotherapy Practice and Research, 7(2), 167-176. 
 
Delmonte, M. M. (1985). Meditation and anxiety reduction: A literature review. Clinical 
Psychology Review, 5, 91-102. 
 
Derogatis, L. R. (1993). Brief symptom inventory: Administration, scoring, and procedures 
manual-ii. Minneapolis, MN: National Computer Systems. 
 
Derogatis, L. R., & Spencer, P. M. (1982). Brief symptom inventory: Administration, scoring, 
and procedures manual-i. Baltimore: Clinical Psychometric Research. 
 
Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The satisfaction with life 
scale. Journal of Personality Assessment, 49(1), 71-75. 
 
Diener, E., Lucas, R. E., & Scollon, C. N. (2006). Beyond the hedonic treadmill: Revising 
the adaptation theory of well-being. American Psychologist, 61(4), 305-314. 
 
  
 
67 
Dunlap, W.P., Cortina, J.M., Vaslow, J.B., & Burke, M.J. (1996). Meta-analysis of 
experiments with matched groups or repeated measures designs. Psychological 
Methods, 1, 170-177. 
 
Earnst, K. S., & Kring, A. M. (1997). Construct validity of negative symptoms: An empirical 
and conceptual review. Clinical Psychology Review, 17(2), 167-189. 
 
Fredrickson, B. L. (1998). What good are positive emotions? Review of General Psychology, 
2, 300-319. 
 
Fredrickson, B. L. (2001). The role of positive emotions in positive psychology. The 
broaden-and-build theory of positive emotions. American Psychologist, 56(3), 218-
226. 
 
Fredrickson, B. L. (2004). The broaden-and-build theory of positive emotions. Philosophical 
Transactions of the Royal Society of London. Series B: Biological Sciences, 
359(1449), 1367-1378. 
 
Fredrickson, B. L., & Branigan, C. (2005). Positive emotions broaden the scope of attention 
and thought-action repertoires. Cognition and Emotion, 19, 313-332. 
 
Fredrickson, B. L., Cohn, M. A., Coffey, K. A., Pek, J., & Finkel, S. M. (2008). Open hearts 
build lives: Positive emotions, induced through loving-kindness meditation, build 
consequential personal resources. Journal of Personality and Social Psychology, 
95(5), 1045-1062. 
 
Fredrickson, B. L., & Joiner, T. (2002). Positive emotions trigger upward spirals toward 
 emotional well-being. Psychological Science, 13 (2), 172-175.  
Fredrickson, B. L., Tugade, M. M., Waugh, C. E., & Larkin, G. R. (2003). What good are 
positive emotions in crises? A prospective study of resilience and emotions following 
the terrorist attacks on the united states on September 11th, 2001. Journal of 
Personality and Social Psychology, 84(2), 365-376. 
 
Gable, S. L., Gonzaga, G. C., & Strachman, A. (2006). Will you be there for me when things 
go right? Supportive responses to positive event disclosures. Journal of Personality 
and Social Psychology Quarterly, 91, 904-917. 
 
Gable, S. L., Reis, H. T., Impett, E. A., & Asher, E. R. (2004). What do you do when things 
go right? The intrapersonal and interpersonal benefits of sharing positive events. 
Journal of Personality and Social Psychology Review, 87, 228-245. 
 
Gammonley, J., Howie, A. R., Kirwin, S., Zapf, S. A., Frye, J., Freeman, G., et al. (1997). 
Animal assisted therapy: Therapeutic interventions. Renton, WA: Delta Society. 
 
  
 
68 
Gard, D. E., Gard, M. G., Kring, A. M., & John, O. P. (2006). Anticipatory and 
consummatory components of the experience of pleasure: A scale development study. 
Journal of Research in Personality, 40(6), 1086. 
 
Gard, D. E., Kring, A. M., Gard, M. G., Horan, W. P., & Green, M. F. (2007). Anhedonia in 
schizophrenia: Distinctions between anticipatory and consummatory pleasure. 
Schizophrenia Research, 93(1-3), 253-260. 
 
Gaudiano, B. A., & Herbert, J. D. (2006). Acute treatment of inpatients with psychotic 
symptoms using acceptance and commitment therapy: Pilot results. Behaviour 
Research and Therapy, 44(3), 415-437. 
 
Gold, C., Heldal, T. O., Dahle, T., & Wigram, T. (2005). Music therapy for schizophrenia or 
schizophrenia-like illnesses (review), Cochrane Database of Systematic Reviews (2 
ed.): Cochrane Database of Systematic Reviews. 
 
Granholm, E., Loh, C., & Swendsen, J. (2008). Feasibility and validity of Computerized 
Ecological Momentary Assessment in schizophrenia. Schizophrenia Bulletin, 34(3), 
507-514. 
 
Grawe, R. W., Falloon, I. R., Widen, J. H., & Skogvoll, E. (2006). Two years of continued 
early treatment for recent-onset schizophrenia: A randomized controlled study. Acta 
Psychiatrica Scandinavica, 114(5), 328-336. 
 
Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and commitment therapy: 
An experiential approach to behaviour change. New York: Guilford. 
 
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. T. (1984). The quality of life scale: An 
instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 
10(3), 388-398. 
 
Herbener, E. S., Harrow, M., & Hill, S. K. (2005). Change in the relationship between 
anhedonia and functional deficits over a 20-year period in individuals with 
schizophrenia. Schizophrenia Research, 75, 97-105. 
 
Hoffman, H., & Kupper, Z. (1997). Relationships between social competence, 
psychopathology and work performance and their predictive value for vocational 
rehabilitation of schizophrenic outpatients. Schizophrenia Research, 23(1), 69-70. 
 
Horan, W. P., Kring, A. M., & Blanchard, J. J. (2006). Anhedonia in schizophrenia: A review 
of assessment strategies. Schizophrenia Bulletin, 32(2), 259-273. 
 
Hutcherson, C. A., Seppala, E. M., & Gross, J. J. (2008). Loving-kindness meditation 
increases social connectedness. Emotion. 8(5), 720-724. 
 
  
 
69 
Isen, A. M. (2000). Positive affect and decision making. In M. Lewis & J. M. Haviland-Jones 
(Eds.), Handbook of emotions (2 ed., pp. 417-435). New York: Guilford Press. 
 
Ivanovski, B., & Malhi, G. S. (2007). The psychological and neurophysiological 
concomitants of mindfulness forms of meditation. Acta Neuropsychiatrica, 19, 76–
91. 
 
Izard, C. E. (1977). Human emotions. New York: Plenum Press. 
 
Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining 
meaningful change in psychotherapy research. Journal of Consulting and Clinical 
Psychology, 59, 12-19. 
 
Johns, L. C. (2002). Battling boredom: Group cognitive behavior therapy for negative 
symptoms of schizophrenia. Behavioural and Cognitive Psychotherapy, 30, 341–346. 
 
Juckel, G., Schlagenhauf, F., Koslowski, M., Wüstenberg, T., Villringer, A., Knutson, B., et 
al. (2006). Dysfunction of ventral striatal reward prediction in schizophrenia. 
Neuroimage, 29, 409-416. 
 
Kabat-Zinn, J. (2003a). Mindfulness-based interventions in context: Past, present, and future. 
Clinical Psychology: Science and Practice, 10, 144-156. 
 
Kabat-Zinn, J. (2003b). Mindfulness-based stress reduction. Constructivism in the Human 
Sciences, 8, 73-107. 
 
Kahneman, D., Krueger, A. B., Schkade, D. A., Schwarz, N., & Stone, A. A. (2004). A 
survey method for characterizing daily life experience: The day reconstruction 
method. Science, 306(5702), 1776-1780. 
 
Keller, M. C., Fredrickson, B. L., Ybarra, O., Cote, S., Johnson, K. J., Mikels, J., Conway, A. 
& Wager, T (2005).  A warm heart and a clear head: The contingent effects of 
weather on mood and cognition. Psychological Science, 16, 724-731. 
 
Kirkpatrick, B., Buchanan, R. W., McKinney, P. D., Alphs, L. D., & Carpenter, W. T. 
(1989). The schedule for the deficit syndrome: An instrument for research in 
schizophrenia. Psychiatry Research, 30, 119-123. 
 
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., Jr., & Marder, S. R. (2006). The NIMH-
MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin, 
32(2), 214-219. 
 
Kopelowicz, A., Liberman, R. P., Mintz, J., & Zarate, R. (1997). Comparison of efficacy of 
social skills training for deficit and nondeficit negative symptoms in schizophrenia. 
American Journal of Psychiatry, 154, 424-425. 
  
 
70 
 
Kraepelin, E. (1919, reprint 1971). Dementia praecox and paraphrenia. New York, NY: RE 
Krieger. 
 
Kring, A. M. (2008). Negative symptom rating scale. Unpublished manuscript. 
 
Larsen, R. J. & Fredrickson, B. L. (1999).  Measurement issues in emotion research.  In D. 
Kahneman, E. Diener & N. Schwarz (Eds.) Well-being: Foundations of hedonic 
psychology (pp. 40-60). New York: Russell Sage. 
 
Lavey, R., Sherman, T., Mueser, K. T., Osborne, D. D., Currier, M., & Wolfe, R. (2005). The 
effects of yoga on mood in psychiatric inpatients. Psychiatric Rehabilitation Journal, 
28(4), 399-402. 
 
Lutz, A., Brefczynski-Lewis, J., Johnstone, T., & Davidson, R. J. (2008). Regulation of the 
neural circuitry of emotion by compassion meditation: Effects of meditative 
expertise., Public Library of Science ONE (Vol. 3). 
 
McGlinchey, J. B., Atkins, D. C., & Jacobson, N. S. (2002). Clinical significance methods: 
Which one to use and how useful are they? Behavior Therapy, 33, 529-550. 
 
Milev, P., Ho, B.-C., Arndt, S., & Andreasen, N. C. (2005). Predictive values of 
neurocognition and negative symptoms on functional outcome in schizophrenia: A 
longitudinal first-episode study with 7-year follow-up. American Journal of 
Psychiatry, 162, 495-506. 
 
Mueser, K. T., Bolton, E., Carty, P. C., Bradley, M. J., Ahlgren, K. F., DiStaso, D. R., et al. 
(2007). The trauma recovery group: A cognitive-behavioral program for post-
traumatic stress disorder in persons with severe mental illness. Community Mental 
Health Journal, 43(3), 281-304. 
 
Mueser, K. T., & Drake, R. E. (2005). How does a practice become evidenced-based? In R. 
E. Drake, M. R. Merrens & D. W. Lynde (Eds.), Evidenced-based mental health 
practice: A textbook (First ed., pp. 217-241). New York: W.W. Norton Company Ltd. 
 
Nathans-Barel, I., Feldman, P., Berger, B., Modai, I., & Silver, H. (2005). Animal-assisted 
therapy ameliorates anhedonia in schizophrenia patients. A controlled pilot study. 
Psychotherapy and Psychosomatics, 74(1), 31-35. 
 
Pavot, W., & Diener, E. (1993). Review of the satisfaction with life scale. Psychological 
Assessment, 5, 164–172. 
 
Peer, J. E., & Spaulding, W. D. (2007). Heterogeneity in recovery of psychosocial 
functioning during psychiatric rehabilitation: An exploratory study using latent 
growth mixture modeling. Schizophrenia Research, 93(1-3), 186-193. 
  
 
71 
 
Penn, D. L., Roberts, D. L., Combs, D., & Sterne, A. (2007). Best practices: The 
development of the social cognition and interaction training program for 
schizophrenia spectrum disorders. Psychiatric Services, 58, 449-451. 
 
Raudenbush, S. W., & Bryk, A. S. (2002). Hierarchical linear models: Applications and data 
analysis methods. California: Sage. 
 
Rector, N. A. (2004). Dysfunctional attitudes and symptom expression in schizophrenia: 
Differential associations with paranoid delusions and negative symptoms. Journal of 
Cognitive Psychotherapy, 18(2), 163-173. 
 
Rector, N. A., Beck, A. T., & Stolar, N. (2005). The negative symptoms of schizophrenia: A 
cognitive perspective. Canadian Journal of Psychiatry, 50(5), 247. 
 
Russinova, Z., Wewiorski, N. J., & Cash, D. (2002). Use of alternative health care practices 
by persons with serious mental illness: Perceived benefits. American Journal of 
Public Health, 92(10), 1600-1603. 
 
Ryan, R. M., & Deci, E. L. (2001). On happiness and human potentials: A review of research 
on hedonic and eudaimonic well-being. Annual Review of Psychology, 52, 141-166. 
 
Ryff, C. (1989). Happiness is everything, or is it? Explorations on the meaning of 
psychological well-being. Journal of Personality and Social Psychology, 57, 1069-
1081. 
 
Salzberg, S. (1995). Loving-kindness: The revolutionary art of happiness. Boston, MA: 
Shambhala. 
 
Scheel, K. R. (2000). The empirical basis of dialectical behaviour therapy: Summary, critique 
and implications. Clinical Psychology: Science and Practice, 7, 68-86. 
 
Schultz, W. (2002). Getting formal with dopamine and reward. Neuron, 36(2), 241-263. 
 
Sears, S. & Kraus, S. (2009). I think therefore I om: Cognitive distortions and coping 
 style as mediators for the effects of mindfulness meditation on anxiety, positive and 
 negative affect, and hope. Journal of Clinical Psychology, 65, 1–13. 
 
Smith, A. J., Becker, S., & Kapur, S. (2005). A computational model of the functional role of 
the ventral-striatal d2 receptor in the expression of previously acquired behaviors. 
Neural Computation, 17, 361-395. 
 
Snyder, C. R., Harris, C., Anderson, J. R., Holleran, S. A., Irving, L. M., Sigmon, S. T. 
 Yoshinobu, L., Gibb, J., Langelle, C., & Harney, P. (1991). The will and the ways: 
 Development and validation of an individual-differences measure of hope. Journal of 
  
 
72 
 Personality and Social Psychology, 60, 570-585. 
 
Spangel, R., & Weiss, F. (1999). The dopamine hypothesis of reward: Past and current status. 
Trends in Neurosciences, 22, 521-527. 
 
Stolar, N. (2004). Cognitive conceptualization of the negative symptoms of schizophrenia. 
Journal of Cognitive Psychotherapy: An International Quarterly, 18, 237-253. 
 
Tarrier, N., & Wykes, T. (2004). Is there evidence that cognitive behaviour therapy is an 
effective treatment for schizophrenia? A cautious or cautionary tale? Behaviour 
Research and Therapy, 42, 1377-1401. 
 
Taylor, S. F., Phan, K. L., Britton, J. C., & Liberzon, I. (2005). Neural response to emotional 
salience in schizophrenia. Neuropsychopharmacology, 30, 984-995. 
 
Teasdale, J. D. (2004). Mindfulness-based cognitive therapy. In J. Yiend (Ed.), Cognition, 
emotion, and psychopathology. (pp. 270–289). UK: Cambridge University Press. 
 
Tek, C., Kirkpatrick, B., & Buchanan, R. W. (2001). A five-year follow-up study of deficit 
and nondeficit schizophrenia. Schizophrenia Research, 49(3), 253-260. 
 
Thorup, A., Petersen, L., Jeppesen, P., Ohlenschlaeger, J., Christensen, T., Krarup, G., et al. 
(2005). Integrated treatment ameliorates negative symptoms in first episode 
psychosis--results from the Danish OPUS trial. Schizophrenia Research, 79(1), 95-
105. 
 
Ulrich, G. (2004). De toegevoegde waarde van groepsmuziektherapie bij schizofrene 
patiënten: Een gerandomiseer onderzoek [the added value of group music therapy 
with schizophrenic patients: A randomised study]. Unpublished manuscript.  
 
Ulrich, G., Houtmans, T., & Gold, C. (2007). The additional therapeutic effect of group 
music therapy for schizophrenic patients: A randomized study. Acta Psychiatrica 
Scandinavica, 116(5), 362-370. 
 
Valencia, M., Rascon, M. L., Juarez, F., & Murow, E. (2007). A psychosocial skills training 
approach in Mexican out-patients with schizophrenia. Psychological Medicine, 
37(10), 1393-1402. 
 
Vauth, R., Corrigan, P. W., Clauss, M., Dietl, M., Dreher-Rudolph, M., Stieglitz, R. D., et al. 
(2005). Cognitive strategies versus self-management skills as adjunct to vocational 
rehabilitation. Schizophrenia Bulletin, 31(1), 55-66. 
 
Waldheter, E. J., Penn, D. L., Perkins, D. O., Mueser, K. T., Owens, L. W., & Cook, E. 
(2008). The graduated recovery intervention program for first episode psychosis: 
  
 
73 
Treatment development and preliminary data. Community Mental Health Journal, 1-
13. 
 
Wallace, B. A., & Shapiro, S. L. (2006). Mental balance and well-being: Building bridges 
between Buddhism and western psychology. American Psychologist, 61, 690-701. 
 
Waugh, C. E., & Fredrickson, B. L. (2006). Nice to know you: Positive emotions, self–other 
overlap, and complex understanding in the formation of a new relationship. The 
Journal of Positive Psychology, 1(2), 93–106. 
 
Weissman, A. (1978). The dysfunctional attitudes scale: A validation study. 
 
Wise, R. A. (2002). Brain reward circuitry: Insights from unsensed incentives. Neuron, 36 
(2), 229-294. 
 
Wittmann, B. C., Schott, B. H., Guderian, S., Frey, J., Heinze, H., & Düzel, E. (2005). 
Reward related fMRI activation of dopaminergic midbrain is associated with 
enhanced hippocampus-dependent longterm memory formation. Neuron, 45, 459-
467. 
 
Wolf, D. H. (2006). Anhedonia in schizophrenia. Current Psychiatry Reports, 8, 322–328. 
 
Wu, C.-H., & Wu, C.-Y. (2008). Life satisfaction in persons with schizophrenia living in the 
community: Validation of the satisfaction with life scale. Social Indicators Research, 
85, 447-460. 
 
Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2008). Cognitive behavior therapy for 
schizophrenia: Effect sizes, clinical models, and methodological rigor. Schizophrenia 
Bulletin, 34(3), 523-537. 
 
Yalom, I. (1995). The theory and practice of group psychotherapy (4th edition ed.). New 
York: Basic Books. 
 
Yang, W.-Y., Li, Z., Weng, Y.-Z., Zhang, H.-Y., Ma, B., YYang, W.-Y., et al. (1998). 
Psychosocial rehabilitation effects of music therapy in chronic schizophrenia. Hong 
Kong Journal of Psychiatry, 8(1), 38–40. 
 
York, M. (2007). A qualitative study into the experience of individuals involved in a 
mindfulness group within an acute inpatient mental health unit. Journal of Psychiatric 
and Mental Health Nursing, 14(6), 603-608. 
 
Yorston, G. A. (2001). Mania precipitated by meditation: A case report and literature review. 
Mental Health, Religion & Culture, 4(2), 209-213. 
 
